1. Huyghe JR, Bien SA, Harrison TA, Kang HM, Chen S, Schmit SL, Conti DV, Qu C, Jeon J, Edlund CK, Greenside P, Wainberg M, Schumacher FR, Smith JD, Levine DM, Nelson SC, Sinnott-Armstrong NA, Albanes D, Alonso MH, Anderson K, Arnau-Collell C, Arndt V, Bamia C, Banbury BL, Baron JA, Berndt SI, Bézieau S, Bishop DT, Boehm J, Boeing H, Brenner H, Brezina S, Buch S, Buchanan DD, Burnett-Hartman A, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Castellví-Bel S, Chan AT, Chang-Claude J, Chanock SJ, Chirlaque MD, Cho SH, Connolly CM, Cross AJ, Cuk K, Curtis KR, de la Chapelle A, Doheny KF, Duggan D, Easton DF, Elias SG, Elliott F, English DR, Feskens EJM, Figueiredo JC, Fischer R, FitzGerald LM, Forman D, Gala M, Gallinger S, Gauderman WJ, Giles GG, Gillanders E, Gong J, Goodman PJ, Grady WM, Grove JS, Gsur A, Gunter MJ, Haile RW, Hampe J, Hampel H, Harlid S, Hayes RB, Hofer P, Hoffmeister M, Hopper JL et al.. Discovery of common and rare genetic risk variants for colorectal cancer.. Nat. Genet. 2018; :. doi: 10.1038/s41588-018-0286-6. PubMed PMID:30510241 .

  2. Wang X, Dai JY, Albanes D, Arndt V, Berndt SI, Bézieau S, Brenner H, Buchanan DD, Butterbach K, Caan B, Casey G, Campbell PT, Chan AT, Chen Z, Chang-Claude J, Cotterchio M, Easton DF, Giles GG, Giovannucci E, Grady WM, Hoffmeister M, Hopper JL, Hsu L, Jenkins MA, Joshi AD, Lampe JW, Larsson SC, Lejbkowicz F, Li L, Lindblom A, Le Marchand L, Martin V, Milne RL, Moreno V, Newcomb PA, Offitt K, Ogino S, Pharoah PDP, Pinchev M, Potter JD, Rennert HS, Rennert G, Saliba W, Schafmayer C, Schoen RE, Schrotz-King P, Slattery ML, Song M, Stegmaier C, Weinstein SJ, Wolk A, Woods MO, Wu AH, Gruber SB, Peters U, White E. Mendelian randomization analysis of C-reactive protein on colorectal cancer risk.. Int J Epidemiol. 2018; :. doi: 10.1093/ije/dyy244. PubMed PMID:30476131 .

  3. Moreno V, Alonso MH, Closa A, Vallés X, Diez-Villanueva A, Valle L, Castellví-Bel S, Sanz-Pamplona R, Lopez-Doriga A, Cordero D, Solé X. Colon-specific eQTL analysis to inform on functional SNPs.. Br. J. Cancer. 2018;119 (8):971-977. doi: 10.1038/s41416-018-0018-9. PubMed PMID:30283144 .

  4. Vallès X, Alonso MH, López-Caleya JF, Díez-Obrero V, Dierssen-Sotos T, Lope V, Molina-Barceló A, Chirlaque MD, Jiménez-Moleón JJ, Fernández Tardón G, Castilla J, Amiano P, Capelo R, Castaño-Vinyals G, Guinó E, Molina de la Torre AJ, Moreno-Iribas C, Pérez Gómez B, Aragonés N, Llorca J, Martín V, Kogevinas M, Pollán M, Moreno V. Colorectal cancer, sun exposure and dietary vitamin D and calcium intake in the MCC-Spain study.. Environ Int. 2018;121 (Pt 1):428-434. doi: 10.1016/j.envint.2018.09.030. PubMed PMID:30266013 .

  5. Lujan-Barroso L, Gibert K, Obón-Santacana M, Chirlaque MD, Sánchez MJ, Larrañaga N, Barricarte A, Quirós JR, Salamanca-Fernández E, Colorado-Yohar S, Gómez-Pozo B, Agudo A, Duell EJ. The influence of lifestyle, diet, and reproductive history on age at natural menopause in Spain: Analysis from the EPIC-Spain sub-cohort.. Am. J. Hum. Biol. 2018;30 (6):e23181. doi: 10.1002/ajhb.23181. PubMed PMID:30251288 .

  6. Martínez-Laguna D, Tebé C, Nogués X, Kassim Javaid M, Cooper C, Moreno V, Diez-Perez A, Collins GS, Prieto-Alhambra D. Fracture risk in type 2 diabetic patients: A clinical prediction tool based on a large population-based cohort.. PLoS ONE. 2018;13 (9):e0203533. doi: 10.1371/journal.pone.0203533. PubMed PMID:30192850 PubMed Central PMC6128577.

  7. Rodriguez-Alonso L, Rodriguez-Moranta F, Arajol C, Gilabert P, Serra K, Martin A, Ibáñez-Sanz G, Moreno V, Guardiola J. Proton pump inhibitors reduce the accuracy of faecal immunochemical test for detecting advanced colorectal neoplasia in symptomatic patients.. PLoS ONE. 2018;13 (8):e0203359. doi: 10.1371/journal.pone.0203359. PubMed PMID:30169524 PubMed Central PMC6118361.

  8. Galván-Femenía I, Obón-Santacana M, Piñeyro D, Guindo-Martinez M, Duran X, Carreras A, Pluvinet R, Velasco J, Ramos L, Aussó S, Mercader JM, Puig L, Perucho M, Torrents D, Moreno V, Sumoy L, de Cid R. Multitrait genome association analysis identifies new susceptibility genes for human anthropometric variation in the GCAT cohort.. J. Med. Genet. 2018;55 (11):765-778. doi: 10.1136/jmedgenet-2018-105437. PubMed PMID:30166351 PubMed Central PMC6252362.

  9. Gómez-Acebo I, Dierssen-Sotos T, Palazuelos C, Fernández-Navarro P, Castaño-Vinyals G, Alonso-Molero J, Urtiaga C, Fernández-Villa T, Ardanaz E, Rivas-Del-Fresno M, Molina-Barceló A, Jiménez-Moleón JJ, García-Martinez L, Amiano P, Rodriguez-Cundin P, Moreno V, Pérez-Gómez B, Aragonés N, Kogevinas M, Pollán M, Llorca J. Pigmentation phototype and prostate and breast cancer in a select Spanish population-A Mendelian randomization analysis in the MCC-Spain study.. PLoS ONE. 2018;13 (8):e0201750. doi: 10.1371/journal.pone.0201750. PubMed PMID:30106959 PubMed Central PMC6091948.

  10. Azuara D, Aussó S, Rodriguez-Moranta F, Guardiola J, Sanjuan X, Lobaton T, Boadas J, Piqueras M, Monfort D, Guinó E, Moreno V, Capellá G, de Oca J. New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients.. Inflamm. Bowel Dis. 2018;24 (12):2555-2564. doi: 10.1093/ibd/izy255. PubMed PMID:30099509 .

  11. O'Callaghan-Gordo C, Kogevinas M, Cirach M, Castaño-Vinyals G, Aragonés N, Delfrade J, Fernández-Villa T, Amiano P, Dierssen-Sotos T, Tardon A, Capelo R, Peiró-Perez R, Moreno V, Roca-Barceló A, Perez-Gomez B, Vidan J, Molina AJ, Oribe M, Gràcia-Lavedan E, Espinosa A, Valentin A, Pollán M, Nieuwenhuijsen MJ. Residential proximity to green spaces and breast cancer risk: The multicase-control study in Spain (MCC-Spain).. Int J Hyg Environ Health. 2018;221 (8):1097-1106. doi: 10.1016/j.ijheh.2018.07.014. PubMed PMID:30076044 .

  12. Kogevinas M, Espinosa A, Castelló A, Gómez-Acebo I, Guevara M, Martin V, Amiano P, Alguacil J, Peiro R, Moreno V, Costas L, Fernández-Tardón G, Jimenez JJ, Marcos-Gragera R, Perez-Gomez B, Llorca J, Moreno-Iribas C, Fernández-Villa T, Oribe M, Aragones N, Papantoniou K, Pollán M, Castano-Vinyals G, Romaguera D. Effect of mistimed eating patterns on breast and prostate cancer risk (MCC-Spain Study).. Int. J. Cancer. 2018;143 (10):2380-2389. doi: 10.1002/ijc.31649. PubMed PMID:30016830 PubMed Central PMC6220994.

  13. Amiano P, Molina-Montes E, Molinuevo A, Huerta JM, Romaguera D, Gracia E, Martín V, Castaño-Vinyals G, Pérez-Gómez B, Moreno V, Castilla J, Gómez-Acebo I, Jiménez-Moleón JJ, Fernández-Tardón G, Chirlaque MD, Capelo R, Salas L, Azpiri M, Fernández-Villa T, Bessa X, Aragonés N, Obón-Santacana M, Guevara M, Dierssen-Sotos T, Barrios-Rodríguez R, de la Torre AJM, Vega AB, Pollán M, Kogevinas M, Sánchez MJ. Association study of dietary non-enzymatic antioxidant capacity (NEAC) and colorectal cancer risk in the Spanish Multicase-Control Cancer (MCC-Spain) study.. Eur J Nutr. 2018; :. doi: 10.1007/s00394-018-1773-3. PubMed PMID:29995245 .

  14. Pimenoff VN, Houldcroft CJ, Rifkin RF, Underdown S. The Role of aDNA in Understanding the Coevolutionary Patterns of Human Sexually Transmitted Infections.. Genes (Basel). 2018;9 (7):. doi: 10.3390/genes9070317. PubMed PMID:29941858 PubMed Central PMC6070984.

  15. Schmit SL, Edlund CK, Schumacher FR, Gong J, Harrison TA, Huyghe JR, Qu C, Melas M, Van Den Berg DJ, Wang H, Tring S, Plummer SJ, Albanes D, Alonso MH, Amos CI, Anton K, Aragaki AK, Arndt V, Barry EL, Berndt SI, Bezieau S, Bien S, Bloomer A, Boehm J, Boutron-Ruault MC, Brenner H, Brezina S, Buchanan DD, Butterbach K, Caan BJ, Campbell PT, Carlson CS, Castelao JE, Chan AT, Chang-Claude J, Chanock SJ, Cheng I, Cheng YW, Chin LS, Church JM, Church T, Coetzee GA, Cotterchio M, Cruz Correa M, Curtis KR, Duggan D, Easton DF, English D, Feskens EJM, Fischer R, FitzGerald LM, Fortini BK, Fritsche LG, Fuchs CS, Gago-Dominguez M, Gala M, Gallinger SJ, Gauderman WJ, Giles GG, Giovannucci EL, Gogarten SM, Gonzalez-Villalpando C, Gonzalez-Villalpando EM, Grady WM, Greenson JK, Gsur A, Gunter M, Haiman CA, Hampe J, Harlid S, Harju JF, Hayes RB, Hofer P, Hoffmeister M, Hopper JL, Huang SC, Huerta JM, Hudson TJ, Hunter DJ, Idos GE et al.. Novel Common Genetic Susceptibility Loci for Colorectal Cancer.. J. Natl. Cancer Inst. 2018; :. doi: 10.1093/jnci/djy099. PubMed PMID:29917119 .

  16. Lopez-Doriga A, Valle L, Alonso MH, Aussó S, Closa A, Sanjuan X, Barquero D, Rodríguez-Moranta F, Sanz-Pamplona R, Moreno V. Telomere length alterations in microsatellite stable colorectal cancer and association with the immune response.. Biochim Biophys Acta Mol Basis Dis. 2018;1864 (9 Pt B):2992-3000. doi: 10.1016/j.bbadis.2018.06.010. PubMed PMID:29908233 .

  17. Mur P, Jemth AS, Bevc L, Amaral N, Navarro M, Valdés-Mas R, Pons T, Aiza G, Urioste M, Valencia A, Lázaro C, Moreno V, Puente XS, Stenmark P, Warpman-Berglund U, Capellá G, Helleday T, Valle L. Germline variation in the oxidative DNA repair genes NUDT1 and OGG1 is not associated with hereditary colorectal cancer or polyposis.. Hum. Mutat. 2018;39 (9):1214-1225. doi: 10.1002/humu.23564. PubMed PMID:29900613 .

  18. Neumeyer S, Banbury BL, Arndt V, Berndt SI, Bezieau S, Bien SA, Buchanan DD, Butterbach K, Caan BJ, Campbell PT, Casey G, Chan AT, Chanock SJ, Dai JY, Gallinger S, Giovannucci EL, Giles GG, Grady WM, Hampe J, Hoffmeister M, Hopper JL, Hsu L, Jenkins MA, Joshi A, Larsson SC, Le Marchand L, Lindblom A, Moreno V, Lemire M, Li L, Lin Y, Offit K, Newcomb PA, Pharaoh PD, Potter JD, Qi L, Rennert G, Schafmayer C, Schoen RE, Slattery ML, Song M, Ulrich CM, Win AK, White E, Wolk A, Woods MO, Wu AH, Gruber SB, Brenner H, Peters U, Chang-Claude J. Mendelian randomisation study of age at menarche and age at menopause and the risk of colorectal cancer.. Br. J. Cancer. 2018;118 (12):1639-1647. doi: 10.1038/s41416-018-0108-8. PubMed PMID:29795306 PubMed Central PMC6008474.

  19. Garcia-Saenz A, Sánchez de Miguel A, Espinosa A, Valentin A, Aragonés N, Llorca J, Amiano P, Martín Sánchez V, Guevara M, Capelo R, Tardón A, Peiró-Perez R, Jiménez-Moleón JJ, Roca-Barceló A, Pérez-Gómez B, Dierssen-Sotos T, Fernández-Villa T, Moreno-Iribas C, Moreno V, García-Pérez J, Castaño-Vinyals G, Pollán M, Aubé M, Kogevinas M. Evaluating the Association between Artificial Light-at-Night Exposure and Breast and Prostate Cancer Risk in Spain (MCC-Spain Study).. Environ. Health Perspect. 2018;126 (4):047011. doi: 10.1289/EHP1837. PubMed PMID:29687979 PubMed Central PMC6071739.

  20. Lope V, Castelló A, Mena-Bravo A, Amiano P, Aragonés N, Fernández-Villa T, Guevara M, Dierssen-Sotos T, Fernandez-Tardón G, Castaño-Vinyals G, Marcos-Gragera R, Moreno V, Salas-Trejo D, Diaz-Santos M, Oribe M, Romieu I, Kogevinas M, Priego-Capote F, Pérez-Gómez B, Pollán M. Serum 25-hydroxyvitamin D and breast cancer risk by pathological subtype (MCC-Spain).. J. Steroid Biochem. Mol. Biol. 2018;182 :4-13. doi: 10.1016/j.jsbmb.2018.04.005. PubMed PMID:29679754 .

  21. Santos C, Sanz-Pamplona R, Salazar R. RET-fusions: a novel paradigm in colorectal cancer.. Ann. Oncol. 2018;29 (6):1340-1343. doi: 10.1093/annonc/mdy132. PubMed PMID:29648570 .

  22. Tebé C, Martinez-Laguna D, Moreno V, Cooper C, Diez-Perez A, Collins GS, Prieto-Alhambra D. Differential Mortality and the Excess Rates of Hip Fracture Associated With Type 2 Diabetes: Accounting for Competing Risks in Fracture Prediction Matters.. J. Bone Miner. Res. 2018;33 (8):1417-1421. doi: 10.1002/jbmr.3435. PubMed PMID:29624726 PubMed Central PMC6108421.

  23. Piulats JM, Vidal A, García-Rodríguez FJ, Muñoz C, Nadal M, Moutinho C, Martínez-Iniesta M, Mora J, Figueras A, Guinó E, Padullés L, Aytés À, Molleví DG, Puertas S, Martínez-Fernández C, Castillo W, Juliachs M, Moreno V, Muñoz P, Stefanovic M, Pujana MA, Condom E, Esteller M, Germà JR, Capella G, Farré L, Morales A, Viñals F, García-Del-Muro X, Cerón J, Villanueva A. Orthoxenografts of Testicular Germ Cell Tumors Demonstrate Genomic Changes Associated with Cisplatin Resistance and Identify PDMP as a Resensitizing Agent.. Clin. Cancer Res. 2018;24 (15):3755-3766. doi: 10.1158/1078-0432.CCR-17-1898. PubMed PMID:29618620 .

  24. Obón-Santacana M, Vilardell M, Carreras A, Duran X, Velasco J, Galván-Femenía I, Alonso T, Puig L, Sumoy L, Duell EJ, Perucho M, Moreno V, de Cid R. GCAT|Genomes for life: a prospective cohort study of the genomes of Catalonia.. BMJ Open. 2018;8 (3):e018324. doi: 10.1136/bmjopen-2017-018324. PubMed PMID:29593016 PubMed Central PMC5875652.

  25. Castelló A, Amiano P, Fernández de Larrea N, Martín V, Alonso MH, Castaño-Vinyals G, Pérez-Gómez B, Olmedo-Requena R, Guevara M, Fernandez-Tardon G, Dierssen-Sotos T, Llorens-Ivorra C, Huerta JM, Capelo R, Fernández-Villa T, Díez-Villanueva A, Urtiaga C, Castilla J, Jiménez-Moleón JJ, Moreno V, Dávila-Batista V, Kogevinas M, Aragonés N, Pollán M, MCC-Spain researchers. Low adherence to the western and high adherence to the mediterranean dietary patterns could prevent colorectal cancer.. Eur J Nutr. 2018; :. doi: 10.1007/s00394-018-1674-5. PubMed PMID:29582162 .

  26. Boldo E, Castelló A, Aragonés N, Amiano P, Pérez-Gómez B, Castaño-Vinyals G, Martín V, Guevara M, Urtiaga C, Dierssen-Sotos T, Fernández-Tardón G, Moreno V, Solans M, Peiró R, Capelo R, Gómez-Acebo I, Castilla J, Molina AJ, Castells X, Altzibar JM, Lope V, Kogevinas M, Romieu I, Pollán M, MCC-Spain researchers. Meat intake, methods and degrees of cooking and breast cancer risk in the MCC-Spain study.. Maturitas. 2018;110 :62-70. doi: 10.1016/j.maturitas.2018.01.020. PubMed PMID:29563037 .

  27. Dierssen-Sotos T, Palazuelos-Calderón C, Jiménez-Moleón JJ, Aragonés N, Altzibar JM, Castaño-Vinyals G, Martín-Sanchez V, Gómez-Acebo I, Guevara M, Tardón A, Pérez-Gómez B, Amiano P, Moreno V, Molina AJ, Alonso-Molero J, Moreno-Iribas C, Kogevinas M, Pollán M, Llorca J. Reproductive risk factors in breast cancer and genetic hormonal pathways: a gene-environment interaction in the MCC-Spain project.. BMC Cancer. 2018;18 (1):280. doi: 10.1186/s12885-018-4182-3. PubMed PMID:29530003 PubMed Central PMC5848450.

  28. García-Pérez J, Lope V, Pérez-Gómez B, Molina AJ, Tardón A, Díaz Santos MA, Ardanaz E, O'Callaghan-Gordo C, Altzibar JM, Gómez-Acebo I, Moreno V, Peiró R, Marcos-Gragera R, Kogevinas M, Aragonés N, López-Abente G, Pollán M. Risk of breast cancer and residential proximity to industrial installations: New findings from a multicase-control study (MCC-Spain).. Environ. Pollut. 2018;237 :559-568. doi: 10.1016/j.envpol.2018.02.065. PubMed PMID:29524878 .

  29. Dierssen-Sotos T, Gómez-Acebo I, Palazuelos C, Fernández-Navarro P, Altzibar JM, González-Donquiles C, Ardanaz E, Bustamante M, Alonso-Molero J, Vidal C, Bayo-Calero J, Tardón A, Salas D, Marcos-Gragera R, Moreno V, Rodriguez-Cundin P, Vinyals GC, Ederra M, Vilorio-Marqués L, Amiano P, Pérez-Gómez B, Aragonés N, Kogevinas M, Pollán M, Llorca J. Validating a breast cancer score in Spanish women. The MCC-Spain study.. Sci Rep. 2018;8 (1):3036. doi: 10.1038/s41598-018-20832-0. PubMed PMID:29445177 PubMed Central PMC5813036.

  30. Ibáñez-Sanz G, Díez-Villanueva A, Vilorio-Marqués L, Gracia E, Aragonés N, Olmedo-Requena R, Llorca J, Vidán J, Amiano P, Nos P, Fernández-Tardón G, Rada R, Chirlaque MD, Guinó E, Dávila-Batista V, Castaño-Vinyals G, Pérez-Gómez B, Mirón-Pozo B, Dierssen-Sotos T, Etxeberria J, Molinuevo A, Álvarez-Cuenllas B, Kogevinas M, Pollán M, Moreno V. Possible role of chondroitin sulphate and glucosamine for primary prevention of colorectal cancer. Results from the MCC-Spain study.. Sci Rep. 2018;8 (1):2040. doi: 10.1038/s41598-018-20349-6. PubMed PMID:29391578 PubMed Central PMC5794904.

  31. Gray P, Palmroth J, Luostarinen T, Apter D, Dubin G, Garnett G, Eriksson T, Natunen K, Merikukka M, Pimenoff V, Söderlund-Strand A, Vänskä S, Paavonen J, Pukkala E, Dillner J, Lehtinen M. Evaluation of HPV type-replacement in unvaccinated and vaccinated adolescent females-Post-hoc analysis of a community-randomized clinical trial (II).. Int. J. Cancer. 2018;142 (12):2491-2500. doi: 10.1002/ijc.31281. PubMed PMID:29377141 .

  32. Clèries R, Ameijide A, Buxó M, Vilardell M, Martínez JM, Alarcón F, Cordero D, Díez-Villanueva A, Yasui Y, Marcos-Gragera R, Vilardell ML, Carulla M, Galceran J, Izquierdo Á, Moreno V, Borràs JM. [WebSurvCa: web-based estimation of death and survival probabilities in a cohort].. Gac Sanit. ;32 (5):492-495. doi: 10.1016/j.gaceta.2017.10.015. PubMed PMID:29357998 .

  33. Font-Ribera L, Gràcia-Lavedan E, Aragonés N, Pérez-Gómez B, Pollán M, Amiano P, Jiménez-Zabala A, Castaño-Vinyals G, Roca-Barceló A, Ardanaz E, Burgui R, Molina AJ, Fernández-Villa T, Gómez-Acebo I, Dierssen-Sotos T, Moreno V, Fernandez-Tardon G, Peiró R, Kogevinas M, Villanueva CM. Long-term exposure to trihalomethanes in drinking water and breast cancer in the Spanish multicase-control study on cancer (MCC-SPAIN).. Environ Int. 2018;112 :227-234. doi: 10.1016/j.envint.2017.12.031. PubMed PMID:29289867 .

  34. Castelló A, Fernández de Larrea N, Martín V, Dávila-Batista V, Boldo E, Guevara M, Moreno V, Castaño-Vinyals G, Gómez-Acebo I, Fernández-Tardón G, Peiró R, Olmedo-Requena R, Capelo R, Navarro C, Pacho-Valbuena S, Pérez-Gómez B, Kogevinas M, Pollán M, Aragonés N, MCC-Spain researchers. High adherence to the Western, Prudent, and Mediterranean dietary patterns and risk of gastric adenocarcinoma: MCC-Spain study.. Gastric Cancer. 2018;21 (3):372-382. doi: 10.1007/s10120-017-0774-x. PubMed PMID:29139048 .

  35. Bellido F, Sowada N, Mur P, Lázaro C, Pons T, Valdés-Mas R, Pineda M, Aiza G, Iglesias S, Soto JL, Urioste M, Caldés T, Balbín M, Blay P, Rueda D, Durán M, Valencia A, Moreno V, Brunet J, Blanco I, Navarro M, Calin GA, Borck G, Puente XS, Capellá G, Valle L. Association Between Germline Mutations in BRF1, a Subunit of the RNA Polymerase III Transcription Complex, and Hereditary Colorectal Cancer.. Gastroenterology. 2018;154 (1):181-194.e20. doi: 10.1053/j.gastro.2017.09.005. PubMed PMID:28912018 .

Search PubMed
  1. Dopeso H, Rodrigues P, Bilic J, Bazzocco S, Cartón-García F, Macaya I, de Marcondes PG, Anguita E, Masanas M, Jiménez-Flores LM, Martínez-Barriocanal Á, Nieto R, Segura MF, Schwartz S Jr, Mariadason JM, Arango D. Mechanisms of inactivation of the tumour suppressor gene RHOA in colorectal cancer.. Br. J. Cancer. 2018;118 (1):106-116. doi: 10.1038/bjc.2017.420. PubMed PMID:29206819 PubMed Central PMC5765235.

  2. Alonso-Molero J, González-Donquiles C, Palazuelos C, Fernández-Villa T, Ramos E, Pollán M, Aragonés N, Llorca J, Henar Alonso M, Tardón A, Amiano P, Moleon JJJ, Pérez RP, Capelo R, Molina AJ, Acebo IG, Guevara M, Perez-Gomez B, Lope V, Huerta JM, Castaño-Vinyals G, Kogevinas M, Moreno V, Martín V. The RS4939827 polymorphism in the SMAD7 GENE and its association with Mediterranean diet in colorectal carcinogenesis.. BMC Med. Genet. 2017;18 (1):122. doi: 10.1186/s12881-017-0485-5. PubMed PMID:29084532 PubMed Central PMC5661920.

  3. Barontini J, Antinucci M, Tofanelli S, Cammalleri M, Dal Monte M, Gemignani F, Vodicka P, Marangoni R, Vodickova L, Kupcinskas J, Vymetalkova V, Forsti A, Canzian F, Stein A, Moreno V, Mastrodonato N, Tavano F, Panza A, Barale R, Landi S, Campa D. Association between polymorphisms of TAS2R16 and susceptibility to colorectal cancer.. BMC Gastroenterol. 2017;17 (1):104. doi: 10.1186/s12876-017-0659-9. PubMed PMID:28915899 PubMed Central PMC5603047.

  4. Fernández de Larrea-Baz N, Pérez-Gómez B, Michel A, Romero B, Lope V, Pawlita M, Fernández-Villa T, Moreno V, Martín V, Willhauck-Fleckenstein M, López-Abente G, Castilla J, Fernández-Tardón G, Dierssen-Sotos T, Santibáñez M, Peiró R, Jiménez-Moleón JJ, Navarro C, Castaño-Vinyals G, Kogevinas M, Pollán M, de Sanjosé S, Del Campo R, Waterboer T, Aragonés N. Helicobacter pylori serological biomarkers of gastric cancer risk in the MCC-Spain case-control Study.. Cancer Epidemiol. 2017;50 (Pt A):76-84. doi: 10.1016/j.canep.2017.08.002. PubMed PMID:28888185 .

  5. Gómez-Acebo I, Dierssen-Sotos T, Fernandez-Navarro P, Palazuelos C, Moreno V, Aragonés N, Castaño-Vinyals G, Jiménez-Monleón JJ, Ruiz-Cerdá JL, Pérez-Gómez B, Ruiz-Dominguez JM, Molero JA, Pollán M, Kogevinas M, Llorca J. Risk Model for Prostate Cancer Using Environmental and Genetic Factors in the Spanish Multi-Case-Control (MCC) Study.. Sci Rep. 2017;7 (1):8994. doi: 10.1038/s41598-017-09386-9. PubMed PMID:28827750 PubMed Central PMC5566549.

  6. Feng YA, Cho K, Lindstrom S, Kraft P, Cormack J, IGAP Consortium, Colorectal Transdisciplinary Study (CORECT), Discovery, Biology, and Risk of Inherited Variants in Breast Cancer (DRIVE), Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE), Transdisciplinary Research in Cancer of the Lung (TRICL), Liang L, Driver JA. Investigating the genetic relationship between Alzheimer's disease and cancer using GWAS summary statistics.. Hum. Genet. 2017;136 (10):1341-1351. doi: 10.1007/s00439-017-1831-6. PubMed PMID:28780673 PubMed Central PMC5693762.

  7. Castelló A, Boldo E, Pérez-Gómez B, Lope V, Altzibar JM, Martín V, Castaño-Vinyals G, Guevara M, Dierssen-Sotos T, Tardón A, Moreno V, Puig-Vives M, Llorens-Ivorra C, Alguacil J, Gómez-Acebo I, Castilla J, Gràcia-Lavedán E, Dávila-Batista V, Kogevinas M, Aragonés N, Amiano P, Pollán M. Adherence to the Western, Prudent and Mediterranean dietary patterns and breast cancer risk: MCC-Spain study.. Maturitas. 2017;103 :8-15. doi: 10.1016/j.maturitas.2017.06.020. PubMed PMID:28778338 .

  8. Fernández-de-Larrea N, Michel A, Romero B, Butt J, Pawlita M, Pérez-Gómez B, Castaño-Vinyals G, Moreno V, Martín V, Amiano P, Castilla J, Fernández-Tardón G, Dierssen-Sotos T, Clofent J, Alguacil J, Huerta JM, Jiménez-Moleón JJ, Barricarte A, Molinuevo A, Fernández-Villa T, Casabonne D, Sierra Á, Kogevinas M, de Sanjosé S, Pollán M, Del Campo R, Waterboer T, Aragonés N. Antibody reactivity against Helicobacter pylori proteins in a sample of the Spanish adult population in 2008-2013.. Helicobacter. 2017;22 (5):. doi: 10.1111/hel.12401. PubMed PMID:28737284 .

  9. Ardevol A, Ibañez-Sanz G, Profitos J, Aracil C, Castellvi JM, Alvarado E, Cachero A, Horta D, Miñana J, Gomez-Pastrana B, Pavel O, Dueñas E, Casas M, Planella M, Castellote J, Villanueva C. Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapies.. Hepatology. 2018;67 (4):1458-1471. doi: 10.1002/hep.29370. PubMed PMID:28714072 .

  10. Alonso MH, Aussó S, Lopez-Doriga A, Cordero D, Guinó E, Solé X, Barenys M, de Oca J, Capella G, Salazar R, Sanz-Pamplona R, Moreno V. Comprehensive analysis of copy number aberrations in microsatellite stable colon cancer in view of stromal component.. Br. J. Cancer. 2017;117 (3):421-431. doi: 10.1038/bjc.2017.208. PubMed PMID:28683472 PubMed Central PMC5537504.

  11. Huerta JM, Chirlaque MD, Molina AJ, Amiano P, Martín V, Fernández-Villa T, Pérez-Gómez B, Moreno V, Burgui R, Gómez-Acebo I, Ramos-Lora M, Fernández-Tardón G, Peiró R, Olmedo-Requena R, Pollán M, Kogevinas M, Castaño-Vinyals G, Aragonés N, Navarro. Physical activity domains and risk of gastric adenocarcinoma in the MCC-Spain case-control study.. PLoS ONE. 2017;12 (7):e0179731. doi: 10.1371/journal.pone.0179731. PubMed PMID:28683070 PubMed Central PMC5500262.

  12. Gausachs M, Borras E, Chang K, Gonzalez S, Azuara D, Delgado Amador A, Lopez-Doriga A, San Lucas FA, Sanjuan X, Paules MJ, Taggart MW, Davies GE, Ehli EA, Fowler J, Moreno V, Pineda M, You YN, Lynch PM, Lazaro C, Navin NE, Scheet PA, Hawk ET, Capella G, Vilar E. Mutational Heterogeneity in and Arises at the Crypt Level and Leads to Polyclonality in Early Colorectal Tumorigenesis.. Clin. Cancer Res. 2017;23 (19):5936-5947. doi: 10.1158/1078-0432.CCR-17-0821. PubMed PMID:28645942 PubMed Central PMC5626604.

  13. Santos C, Azuara D, Garcia-Carbonero R, Alfonso PG, Carrato A, Elez ME, Gomez A, Losa F, Montagut C, Massuti B, Navarro V, Varela M, Lopez-Doriga A, Moreno V, Valladares M, Manzano JL, Vieitez JM, Aranda E, Sanjuan X, Tabernero J, Capella G, Salazar R. Optimization of Mutational Analysis Confirms Improvement in Patient Selection for Clinical Benefit to Anti-EGFR Treatment in Metastatic Colorectal Cancer.. Mol. Cancer Ther. 2017;16 (9):1999-2007. doi: 10.1158/1535-7163.MCT-17-0153. PubMed PMID:28626084 .

  14. Fernández de Larrea-Baz N, Michel A, Romero B, Pérez-Gómez B, Moreno V, Martín V, Dierssen-Sotos T, Jiménez-Moleón JJ, Castilla J, Tardón A, Ruiz I, Peiró R, Tejada A, Chirlaque MD, Butt JA, Olmedo-Requena R, Gómez-Acebo I, Linares P, Boldo E, Castells A, Pawlita M, Castaño-Vinyals G, Kogevinas M, de Sanjosé S, Pollán M, Del Campo R, Waterboer T, Aragonés N. Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain.. Front Microbiol. 2017;8 :888. doi: 10.3389/fmicb.2017.00888. PubMed PMID:28611733 PubMed Central PMC5447227.

  15. Romaguera D, Gracia-Lavedan E, Molinuevo A, de Batlle J, Mendez M, Moreno V, Vidal C, Castelló A, Pérez-Gómez B, Martín V, Molina AJ, Dávila-Batista V, Dierssen-Sotos T, Gómez-Acebo I, Llorca J, Guevara M, Castilla J, Urtiaga C, Llorens-Ivorra C, Fernández-Tardón G, Tardón A, Lorca JA, Marcos-Gragera R, Huerta JM, Olmedo-Requena R, Jimenez-Moleon JJ, Altzibar J, de Sanjosé S, Pollán M, Aragonés N, Castaño-Vinyals G, Kogevinas M, Amiano P. Adherence to nutrition-based cancer prevention guidelines and breast, prostate and colorectal cancer risk in the MCC-Spain case-control study.. Int. J. Cancer. 2017;141 (1):83-93. doi: 10.1002/ijc.30722. PubMed PMID:28380695 .

  16. Mateo-Lozano S, Bazzocco S, Rodrigues P, Mazzolini R, Andretta E, Dopeso H, Fernández Y, Del Llano E, Bilic J, Suárez-López L, Macaya I, Cartón-García F, Nieto R, Jimenez-Flores LM, de Marcondes PG, Nuñez Y, Afonso E, Cacci K, Hernández-Losa J, Landolfi S, Abasolo I, Ramón Y Cajal S, Mariadason JM, Schwartz S Jr, Matsui T, Arango D. Loss of the EPH receptor B6 contributes to colorectal cancer metastasis.. Sci Rep. 2017;7 :43702. doi: 10.1038/srep43702. PubMed PMID:28262839 PubMed Central PMC5337985.

  17. Papantoniou K, Castaño-Vinyals G, Espinosa A, Turner MC, Alonso-Aguado MH, Martin V, Aragonés N, Pérez-Gómez B, Pozo BM, Gómez-Acebo I, Ardanaz E, Altzibar JM, Peiro R, Tardon A, Lorca JA, Chirlaque MD, García-Palomo A, Jimenez-Moleon JJ, Ierssen T, Ederra M, Amiano P, Pollan M, Moreno V, Kogevinas M. Shift work and colorectal cancer risk in the MCC-Spain case-control study.. Scand J Work Environ Health. 2017;43 (3):250-259. doi: 10.5271/sjweh.3626. PubMed PMID:28251241 .

  18. Ibáñez-Sanz G, Díez-Villanueva A, Alonso MH, Rodríguez-Moranta F, Pérez-Gómez B, Bustamante M, Martin V, Llorca J, Amiano P, Ardanaz E, Tardón A, Jiménez-Moleón JJ, Peiró R, Alguacil J, Navarro C, Guinó E, Binefa G, Fernández-Navarro P, Espinosa A, Dávila-Batista V, Molina AJ, Palazuelos C, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, Moreno V. Risk Model for Colorectal Cancer in Spanish Population Using Environmental and Genetic Factors: Results from the MCC-Spain study.. Sci Rep. 2017;7 :43263. doi: 10.1038/srep43263. PubMed PMID:28233817 PubMed Central PMC5324108.

  19. Andretta E, Cartón-García F, Martínez-Barriocanal Á, de Marcondes PG, Jimenez-Flores LM, Macaya I, Bazzocco S, Bilic J, Rodrigues P, Nieto R, Landolfi S, Ramon Y Cajal S, Schwartz S, Brown A, Dopeso H, Arango D. Investigation of the role of tyrosine kinase receptor EPHA3 in colorectal cancer.. Sci Rep. 2017;7 :41576. doi: 10.1038/srep41576. PubMed PMID:28169277 PubMed Central PMC5294649.

  20. Toth R, Scherer D, Kelemen LE, Risch A, Hazra A, Balavarca Y, Issa JJ, Moreno V, Eeles RA, Ogino S, Wu X, Ye Y, Hung RJ, Goode EL, Ulrich CM, OCAC, CORECT, TRICL, ELLIPSE, DRIVE, and GAME-ON consortia. Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium.. Cancer Epidemiol. Biomarkers Prev. 2017;26 (6):816-825. doi: 10.1158/1055-9965.EPI-16-0728. PubMed PMID:28115406 PubMed Central PMC6054308.

  21. Piulats JM, Guerra E, Gil-Martín M, Roman-Canal B, Gatius S, Sanz-Pamplona R, Velasco A, Vidal A, Matias-Guiu X. Molecular approaches for classifying endometrial carcinoma.. Gynecol. Oncol. 2017;145 (1):200-207. doi: 10.1016/j.ygyno.2016.12.015. PubMed PMID:28040204 .

  22. Macauda A, Calvetti D, Maccari G, Hemminki K, Försti A, Goldschmidt H, Weinhold N, Houlston R, Andersen V, Vogel U, Buda G, Varkonyi J, Sureda A, Martinez Lopez J, Watek M, Butrym A, Sarasquete ME, Dudziński M, Jurczyszyn A, Druzd-Sitek A, Kruszewski M, Subocz E, Petrini M, Iskierka-Jażdżewska E, Raźny M, Szombath G, Marques H, Zawirska D, Chraniuk D, Halka J, Hove Jacobsen SE, Mazur G, García Sanz R, Dumontet C, Moreno V, Stępień A, Beider K, Pelosini M, Manuel Reis R, Krawczyk-Kulis M, Rymko M, Avet-Loiseau H, Lesueur F, Grząśko N, Ostrovsky O, Jamroziak K, Vangsted AJ, Jerez A, Tomczak W, Zaucha JM, Kadar K, Sainz J, Nagler A, Landi S, Gemignani F, Canzian F. Identification of miRSNPs associated with the risk of multiple myeloma.. Int. J. Cancer. 2017;140 (3):526-534. doi: 10.1002/ijc.30465. PubMed PMID:27718532 .

  23. Ibañez-Sanz G, Garcia M, Milà N, Rodríguez-Moranta F, Binefa G, Gómez-Matas J, Benito L, Padrol I, Barenys M, Moreno V. False-negative rate cannot be reduced by lowering the haemoglobin concentration cut-off in colorectal cancer screening using faecal immunochemical test.. Eur. J. Cancer Prev. 2017;26 (5):365-367. doi: 10.1097/CEJ.0000000000000281. PubMed PMID:27433880 .

  24. Villanueva CM, Gracia-Lavedan E, Bosetti C, Righi E, Molina AJ, Martín V, Boldo E, Aragonés N, Perez-Gomez B, Pollan M, Acebo IG, Altzibar JM, Zabala AJ, Ardanaz E, Peiró R, Tardón A, Chirlaque MD, Tavani A, Polesel J, Serraino D, Pisa F, Castaño-Vinyals G, Espinosa A, Espejo-Herrera N, Palau M, Moreno V, La Vecchia C, Aggazzotti G, Nieuwenhuijsen MJ, Kogevinas M. Colorectal Cancer and Long-Term Exposure to Trihalomethanes in Drinking Water: A Multicenter Case-Control Study in Spain and Italy.. Environ. Health Perspect. 2017;125 (1):56-65. doi: 10.1289/EHP155. PubMed PMID:27383820 PubMed Central PMC5226692.

Search PubMed
  1. de Batlle J, Gracia-Lavedan E, Romaguera D, Mendez M, Castaño-Vinyals G, Martín V, Aragonés N, Gómez-Acebo I, Olmedo-Requena R, Jimenez-Moleon JJ, Guevara M, Azpiri M, Llorens-Ivorra C, Fernandez-Tardon G, Lorca JA, Huerta JM, Moreno V, Boldo E, Pérez-Gómez B, Castilla J, Fernández-Villa T, Barrio JP, Andreu M, Castells A, Dierssen T, Altzibar JM, Kogevinas M, Pollán M, Amiano P. Meat intake, cooking methods and doneness and risk of colorectal tumours in the Spanish multicase-control study (MCC-Spain).. Eur J Nutr. 2018;57 (2):643-653. doi: 10.1007/s00394-016-1350-6. PubMed PMID:27885555 .

  2. Belhadj S, Mur P, Navarro M, González S, Moreno V, Capellá G, Valle L. Delineating the Phenotypic Spectrum of the NTHL1-Associated Polyposis.. Clin. Gastroenterol. Hepatol. 2017;15 (3):461-462. doi: 10.1016/j.cgh.2016.09.153. PubMed PMID:27720914 .

  3. Lope V, Fernández de Larrea N, Pérez-Gómez B, Martín V, Moreno V, Costas L, Longo F, Jiménez-Moleón JJ, Llorca J, Ascunce N, Peiró-Pérez R, Altzibar JM, Tardón A, Alguacil J, Navarro C, Sierra Á, Vega AB, Villafañe A, Castaño-Vinyals G, Kogevinas M, Pollán M, Aragonés N. Menstrual and Reproductive Factors and Risk of Gastric and Colorectal Cancer in Spain.. PLoS ONE. 2016;11 (10):e0164620. doi: 10.1371/journal.pone.0164620. PubMed PMID:27776142 PubMed Central PMC5077095.

  4. Rosato V, Tavani A, Gracia-Lavedan E, Guinó E, Castaño-Vinyals G, Villanueva CM, Kogevinas M, Polesel J, Serraino D, Pisa FE, Barbone F, Moreno V, La Vecchia C, Bosetti C. Type 2 Diabetes, Antidiabetic Medications, and Colorectal Cancer Risk: Two Case-Control Studies from Italy and Spain.. Front Oncol. 2016;6 :210. doi: 10.3389/fonc.2016.00210. PubMed PMID:27766252 PubMed Central PMC5052265.

  5. Dierssen-Sotos T, Gómez-Acebo I, de Pedro M, Pérez-Gómez B, Servitja S, Moreno V, Amiano P, Fernandez-Villa T, Barricarte A, Tardon A, Diaz-Santos M, Peiro-Perez R, Marcos-Gragera R, Lope V, Gracia-Lavedan E, Alonso MH, Michelena-Echeveste MJ, Garcia-Palomo A, Guevara M, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, Llorca J. Use of non-steroidal anti-inflammatory drugs and risk of breast cancer: The Spanish Multi-Case-control (MCC) study.. BMC Cancer. 2016;16 (1):660. doi: 10.1186/s12885-016-2692-4. PubMed PMID:27542890 PubMed Central PMC4992258.

  6. Gómez-Acebo I, Dierssen-Sotos T, Palazuelos C, Pérez-Gómez B, Lope V, Tusquets I, Alonso MH, Moreno V, Amiano P, Molina de la Torre AJ, Barricarte A, Tardon A, Camacho A, Peiro-Perez R, Marcos-Gragera R, Muñoz M, Michelena-Echeveste MJ, Ortega Valin L, Guevara M, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, Llorca J. The Use of Antihypertensive Medication and the Risk of Breast Cancer in a Case-Control Study in a Spanish Population: The MCC-Spain Study.. PLoS ONE. 2016;11 (8):e0159672. doi: 10.1371/journal.pone.0159672. PubMed PMID:27508297 PubMed Central PMC4979888.

  7. Kehlet SN, Sanz-Pamplona R, Brix S, Leeming DJ, Karsdal MA, Moreno V. Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients.. Sci Rep. 2016;6 :30599. doi: 10.1038/srep30599. PubMed PMID:27465284 PubMed Central PMC4964349.

  8. Ibañez-Sanz G, Garcia M, Milà N, Rodríguez-Moranta F, Binefa G, Gómez-Matas J, Benito L, Padrol I, Barenys M, Moreno V. False-negative rate cannot be reduced by lowering the haemoglobin concentration cut-off in colorectal cancer screening using faecal immunochemical test.. Eur. J. Cancer Prev. 2017;26 (5):365-367. doi: 10.1097/CEJ.0000000000000281. PubMed PMID:27433880 .

  9. Ibáñez-Sanz G, Garcia M, Rodríguez-Moranta F, Binefa G, Gómez-Matas J, Domènech X, Vidal C, Soriano A, Moreno V, ‘Adverse Effects on Colorectal Cancer Screening in Catalonia (EACC) Study’ Working Group. Prescription drugs associated with false-positive results when using faecal immunochemical tests for colorectal cancer screening.. Dig Liver Dis. 2016;48 (10):1249-54. doi: 10.1016/j.dld.2016.06.011. PubMed PMID:27378703 .

  10. Caravagna G, Graudenzi A, Ramazzotti D, Sanz-Pamplona R, De Sano L, Mauri G, Moreno V, Antoniotti M, Mishra B. Algorithmic methods to infer the evolutionary trajectories in cancer progression.. Proc. Natl. Acad. Sci. U.S.A. 2016;113 (28):E4025-34. doi: 10.1073/pnas.1520213113. PubMed PMID:27357673 PubMed Central PMC4948322.

  11. Gyarmati G, Turner MC, Castaño-Vinyals G, Espinosa A, Papantoniou K, Alguacil J, Costas L, Pérez-Gómez B, Martin Sanchez V, Ardanaz E, Moreno V, Gómez-Acebo I, Fernández-Tardon G, Villanueva Ballester V, Capelo R, Chirlaque MD, Santibáñez M, Pollán M, Aragonés N, Kogevinas M. Night shift work and stomach cancer risk in the MCC-Spain study.. Occup Environ Med. 2016;73 (8):520-7. doi: 10.1136/oemed-2016-103597. PubMed PMID:27312400 .

  12. Cantariño N, Musulén E, Valero V, Peinado MA, Perucho M, Moreno V, Forcales SV, Douet J, Buschbeck M. Downregulation of the Deiminase PADI2 Is an Early Event in Colorectal Carcinogenesis and Indicates Poor Prognosis.. Mol. Cancer Res. 2016;14 (9):841-8. doi: 10.1158/1541-7786.MCR-16-0034. PubMed PMID:27280713 .

  13. Azuara D, Santos C, Lopez-Doriga A, Grasselli J, Nadal M, Sanjuan X, Marin F, Vidal J, Montal R, Moreno V, Bellosillo B, Argiles G, Elez E, Dienstmann R, Montagut C, Tabernero J, Capellá G, Salazar R. Nanofluidic Digital PCR and Extended Genotyping of RAS and BRAF for Improved Selection of Metastatic Colorectal Cancer Patients for Anti-EGFR Therapies.. Mol. Cancer Ther. 2016;15 (5):1106-12. doi: 10.1158/1535-7163.MCT-15-0820. PubMed PMID:27037411 .

  14. Ibáñez-Sanz G, Gornals JB, Rivas L, Salord S, Paúles MJ, Botargues JM, Galán M. Endoscopic band ligation without resection in selected patients for small and superficial upper gastrointestinal tract lesions.. Rev Esp Enferm Dig. 2016;108 (5):250-6. doi: 10.17235/reed.2016.4031/2015. PubMed PMID:27022723 .

  15. Zeng C, Matsuda K, Jia WH, Chang J, Kweon SS, Xiang YB, Shin A, Jee SH, Kim DH, Zhang B, Cai Q, Guo X, Long J, Wang N, Courtney R, Pan ZZ, Wu C, Takahashi A, Shin MH, Matsuo K, Matsuda F, Gao YT, Oh JH, Kim S, Jung KJ, Ahn YO, Ren Z, Li HL, Wu J, Shi J, Wen W, Yang G, Li B, Ji BT, Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), Brenner H, Schoen RE, Küry S, Colorectal Transdisciplinary (CORECT) Study, Gruber SB, Schumacher FR, Stenzel SL, Colon Cancer Family Registry (CCFR), Casey G, Hopper JL, Jenkins MA, Kim HR, Jeong JY, Park JW, Tajima K, Cho SH, Kubo M, Shu XO, Lin D, Zeng YX, Zheng W. Identification of Susceptibility Loci and Genes for Colorectal Cancer Risk.. Gastroenterology. 2016;150 (7):1633-1645. doi: 10.1053/j.gastro.2016.02.076. PubMed PMID:26965516 PubMed Central PMC4909543.

  16. Espejo-Herrera N, Gràcia-Lavedan E, Boldo E, Aragonés N, Pérez-Gómez B, Pollán M, Molina AJ, Fernández T, Martín V, La Vecchia C, Bosetti C, Tavani A, Polesel J, Serraino D, Gómez Acebo I, Altzibar JM, Ardanaz E, Burgui R, Pisa F, Fernández-Tardón G, Tardón A, Peiró R, Navarro C, Castaño-Vinyals G, Moreno V, Righi E, Aggazzotti G, Basagaña X, Nieuwenhuijsen M, Kogevinas M, Villanueva CM. Colorectal cancer risk and nitrate exposure through drinking water and diet.. Int. J. Cancer. 2016;139 (2):334-46. doi: 10.1002/ijc.30083. PubMed PMID:26954527 .

  17. Ibáñez-Sanz G, Rodríguez-Alonso L, Romero NM. Spontaneous intramural esophageal dissection: an unusual onset of eosinophilic esophagitis.. Rev Esp Enferm Dig. 2016;108 (3):156-7. . PubMed PMID:26949147 .

  18. Sanz-Pamplona R, Gil-Hoyos R, López-Doriga A, Alonso MH, Aussó S, Molleví DG, Santos C, Sanjuán X, Salazar R, Alemany R, Moreno V. Mutanome and expression of immune response genes in microsatellite stable colon cancer.. Oncotarget. 2016;7 (14):17711-25. doi: 10.18632/oncotarget.7293. PubMed PMID:26871478 PubMed Central PMC4951244.

  19. Mur P, Sánchez-Cuartielles E, Aussó S, Aiza G, Valdés-Mas R, Pineda M, Navarro M, Brunet J, Urioste M, Lázaro C, Moreno V, Capellá G, Puente XS, Valle L. Scarce evidence of the causal role of germline mutations in UNC5C in hereditary colorectal cancer and polyposis.. Sci Rep. 2016;6 :20697. doi: 10.1038/srep20697. PubMed PMID:26852919 PubMed Central PMC4745060.

  20. Casabonne D, Gracia E, Espinosa A, Bustamante M, Benavente Y, Robles C, Costas L, Alonso E, Gonzalez-Barca E, Tardón A, Dierssen-Sotos T, Vázquez EG, Aymerich M, Campo E, Jiménez-Moleón JJ, Marcos-Gragera R, Castaño-Vinyals G, Aragones N, Pollan M, Kogevinas M, Urtiaga C, Amiano P, Moreno V, de Sanjose S. Fruit and vegetable intake and vitamin C transporter gene (SLC23A2) polymorphisms in chronic lymphocytic leukaemia.. Eur J Nutr. 2017;56 (3):1123-1133. doi: 10.1007/s00394-016-1162-8. PubMed PMID:26838684 .

  21. Binefa G, Garcia M, Milà N, Fernández E, Rodríguez-Moranta F, Gonzalo N, Benito L, Clopés A, Guardiola J, Moreno V. Colorectal Cancer Screening Programme in Spain: Results of Key Performance Indicators After Five Rounds (2000-2012).. Sci Rep. 2016;6 :19532. doi: 10.1038/srep19532. PubMed PMID:26787510 PubMed Central PMC4726304.

  22. Lope V, García-Esquinas E, Pérez-Gómez B, Altzibar JM, Gracia-Lavedan E, Ederra M, Molina de la Torre AJ, LLorca FJ, Tardón A, Moreno V, Bayo J, Salas-Trejo D, Marcos-Gragera R, Pumarega J, Dierssen-Sotos T, Lera JP, de Miguel Medina MA, Tusquets I, Amiano P, Boldo E, Kogevinas M, Aragonés N, Castaño-Vinyals G, Pollán M. Perinatal and childhood factors and risk of breast cancer subtypes in adulthood.. Cancer Epidemiol. 2016;40 :22-30. doi: 10.1016/j.canep.2015.11.004. PubMed PMID:26613540 .

  23. Butt J, Romero-Hernández B, Pérez-Gómez B, Willhauck-Fleckenstein M, Holzinger D, Martin V, Moreno V, Linares C, Dierssen-Sotos T, Barricarte A, Tardón A, Altzibar JM, Moreno-Osset E, Franco F, Requena RO, Huerta JM, Michel A, Waterboer T, Castaño-Vinyals G, Kogevinas M, Pollán M, Boleij A, de Sanjosé S, Del Campo R, Tjalsma H, Aragonés N, Pawlita M. Association of Streptococcus gallolyticus subspecies gallolyticus with colorectal cancer: Serological evidence.. Int. J. Cancer. 2016;138 (7):1670-9. doi: 10.1002/ijc.29914. PubMed PMID:26537841 .

  24. Sáez MA, Fernández-Rodríguez J, Moutinho C, Sanchez-Mut JV, Gomez A, Vidal E, Petazzi P, Szczesna K, Lopez-Serra P, Lucariello M, Lorden P, Delgado-Morales R, de la Caridad OJ, Huertas D, Gelpí JL, Orozco M, López-Doriga A, Milà M, Perez-Jurado LA, Pineda M, Armstrong J, Lázaro C, Esteller M. Mutations in JMJD1C are involved in Rett syndrome and intellectual disability.. Genet. Med. 2016;18 (4):378-85. doi: 10.1038/gim.2015.100. PubMed PMID:26181491 PubMed Central PMC4823641.

Search PubMed
  1. Mur P, Aiza G, Sanz-Pamplona R, González S, Navarro M, Moreno V, Capellá G, Valle L. AMER1 Is a Frequently Mutated Gene in Colorectal Cancer--Letter.. Clin. Cancer Res. 2015;21 (21):4985. doi: 10.1158/1078-0432.CCR-15-1756. PubMed PMID:26527806 .

  2. Martínez-Aranda A, Hernández V, Guney E, Muixí L, Foj R, Baixeras N, Cuadras D, Moreno V, Urruticoechea A, Gil M, Oliva B, Moreno F, González-Suarez E, Vidal N, Andreu X, Seguí MA, Ballester R, Castella E, Sierra A. FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies.. Oncotarget. 2015;6 (42):44254-73. doi: 10.18632/oncotarget.5471. PubMed PMID:26497551 PubMed Central PMC4792555.

  3. Zamora-Ros R, Guinó E, Alonso MH, Vidal C, Barenys M, Soriano A, Moreno V. Dietary flavonoids, lignans and colorectal cancer prognosis.. Sci Rep. 2015;5 :14148. doi: 10.1038/srep14148. PubMed PMID:26369380 PubMed Central PMC4572925.

  4. Domènech X, Garcia M, Benito L, Binefa G, Vidal C, Milà N, Moreno V. [Interval cancers and episode sensitivity in population-based screening programmes for colorectal cancer: a systematic review].. Gac Sanit. ;29 (6):464-71. doi: 10.1016/j.gaceta.2015.07.002. PubMed PMID:26341155 .

  5. Cebola I, Custodio J, Muñoz M, Díez-Villanueva A, Paré L, Prieto P, Aussó S, Coll-Mulet L, Boscá L, Moreno V, Peinado MA. Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancer.. Clin Epigenetics. 2015;7 :74. doi: 10.1186/s13148-015-0110-4. PubMed PMID:26207152 PubMed Central PMC4512023.

  6. Schumacher FR, Schmit SL, Jiao S, Edlund CK, Wang H, Zhang B, Hsu L, Huang SC, Fischer CP, Harju JF, Idos GE, Lejbkowicz F, Manion FJ, McDonnell K, McNeil CE, Melas M, Rennert HS, Shi W, Thomas DC, Van Den Berg DJ, Hutter CM, Aragaki AK, Butterbach K, Caan BJ, Carlson CS, Chanock SJ, Curtis KR, Fuchs CS, Gala M, Giovannucc EL, Giocannucci EL, Gogarten SM, Hayes RB, Henderson B, Hunter DJ, Jackson RD, Kolonel LN, Kooperberg C, Küry S, Kury S, LaCroix A, Laurie CC, Laurie CA, Lemire M, Lemire M, Levine D, Ma J, Makar KW, Qu C, Taverna D, Ulrich CM, Wu K, Kono S, West DW, Berndt SI, Bezieau S, Brenner H, Campbell PT, Chan AT, Chang-Claude J, Coetzee GA, Conti DV, Duggan D, Figueiredo JC, Fortini BK, Gallinger SJ, Gauderman WJ, Giles G, Green R, Haile R, Harrison TA, Hoffmeister M, Hopper JL, Hudson TJ, Jacobs E, Iwasaki M, Jee SH, Jenkins M, Jia WH, Joshi A et al.. Genome-wide association study of colorectal cancer identifies six new susceptibility loci.. Nat Commun. 2015;6 :7138. doi: 10.1038/ncomms8138. PubMed PMID:26151821 PubMed Central PMC4967357.

  7. Costas L, Sequera VG, Quesada P, Altzibar JM, Lope V, Pérez-Gómez B, Benavente Y, Martín V, Casabonne D, Robles C, Llorca J, Moreno-Iribas C, Fernandez-Tardón G, Moreno V, Caballero-Granado FJ, Salas D, Jiménez-Moleón JJ, Marcos-Gragera R, Chirlaque MD, Amiano P, Molina AJ, Castaño-Vinyals G, Aragonés N, Kogevinas M, Pollán M, de Sanjosé S. Hormonal contraception and postmenopausal hormone therapy in Spain: time trends and patterns of use.. Menopause. 2015;22 (10):1138-46. doi: 10.1097/GME.0000000000000487. PubMed PMID:26125537 .

  8. Ríos R, Lupiañez CB, Campa D, Martino A, Martínez-López J, Martínez-Bueno M, Varkonyi J, García-Sanz R, Jamroziak K, Dumontet C, Cayuela AJ, Wętek M, Landi S, Rossi AM, Lesueur F, Reis RM, Moreno V, Marques H, Jurczyszyn A, Andersen V, Vogel U, Buda G, Orciuolo E, Jacobsen SE, Petrini M, Vangsted AJ, Gemignani F, Canzian F, Jurado M, Sainz J. Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium.. Endocr. Relat. Cancer. 2015;22 (4):545-59. doi: 10.1530/ERC-15-0029. PubMed PMID:26099684 .

  9. Sanz-Pamplona R, Lopez-Doriga A, Paré-Brunet L, Lázaro K, Bellido F, Alonso MH, Aussó S, Guinó E, Beltrán S, Castro-Giner F, Gut M, Sanjuan X, Closa A, Cordero D, Morón-Duran FD, Soriano A, Salazar R, Valle L, Moreno V. Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer.. Clin. Cancer Res. 2015;21 (20):4709-18. doi: 10.1158/1078-0432.CCR-15-0159. PubMed PMID:26071483 PubMed Central PMC4609254.

  10. Rodríguez-Alonso L, Rodríguez-Moranta F, Ruiz-Cerulla A, Lobatón T, Arajol C, Binefa G, Moreno V, Guardiola J. An urgent referral strategy for symptomatic patients with suspected colorectal cancer based on a quantitative immunochemical faecal occult blood test.. Dig Liver Dis. 2015;47 (9):797-804. doi: 10.1016/j.dld.2015.05.004. PubMed PMID:26055489 .

  11. Seguí N, Mina LB, Lázaro C, Sanz-Pamplona R, Pons T, Navarro M, Bellido F, López-Doriga A, Valdés-Mas R, Pineda M, Guinó E, Vidal A, Soto JL, Caldés T, Durán M, Urioste M, Rueda D, Brunet J, Balbín M, Blay P, Iglesias S, Garré P, Lastra E, Sánchez-Heras AB, Valencia A, Moreno V, Pujana MÁ, Villanueva A, Blanco I, Capellá G, Surrallés J, Puente XS, Valle L. Germline Mutations in FAN1 Cause Hereditary Colorectal Cancer by Impairing DNA Repair.. Gastroenterology. 2015;149 (3):563-6. doi: 10.1053/j.gastro.2015.05.056. PubMed PMID:26052075 .

  12. Salas LA, Bustamante M, Gonzalez JR, Gracia-Lavedan E, Moreno V, Kogevinas M, Villanueva CM. DNA methylation levels and long-term trihalomethane exposure in drinking water: an epigenome-wide association study.. Epigenetics. 2015;10 (7):650-61. doi: 10.1080/15592294.2015.1057672. PubMed PMID:26039576 PubMed Central PMC4622514.

  13. García-Esquinas E, Guinó E, Castaño-Vinyals G, Pérez-Gómez B, Llorca J, Altzibar JM, Peiró-Pérez R, Martín V, Moreno-Iribas C, Tardón A, Caballero FJ, Puig-Vives M, Guevara M, Villa TF, Salas D, Amiano P, Dierssen-Sotos T, Pastor-Barriuso R, Sala M, Kogevinas M, Aragonés N, Moreno V, Pollán M. Association of diabetes and diabetes treatment with incidence of breast cancer.. Acta Diabetol. 2016;53 (1):99-107. doi: 10.1007/s00592-015-0756-6. PubMed PMID:25916213 PubMed Central PMC4749645.

  14. Moreno V, Sanz-Pamplona R. Altered pathways and colorectal cancer prognosis.. BMC Med. 2015;13 :76. doi: 10.1186/s12916-015-0307-6. PubMed PMID:25885526 PubMed Central PMC4389340.

  15. Bu P, Wang L, Chen KY, Rakhilin N, Sun J, Closa A, Tung KL, King S, Kristine Varanko A, Xu Y, Huan Chen J, Zessin AS, Shealy J, Cummings B, Hsu D, Lipkin SM, Moreno V, Gümüş ZH, Shen X. miR-1269 promotes metastasis and forms a positive feedback loop with TGF-β.. Nat Commun. 2015;6 :6879. doi: 10.1038/ncomms7879. PubMed PMID:25872451 PubMed Central PMC4399006.

  16. Garcia M, Domènech X, Vidal C, Torné E, Milà N, Binefa G, Benito L, Moreno V. Interval cancers in a population-based screening program for colorectal cancer in catalonia, Spain.. Gastroenterol Res Pract. 2015;2015 :672410. doi: 10.1155/2015/672410. PubMed PMID:25802515 PubMed Central PMC4354714.

  17. Peiró-Pérez R, Salas D, Vallés G, Abad-Fernandez MS, Vidal C, Sanchez-Contador Escudero C, Ascunce-Elizaga N, Zubizarreta R, Pedraz C, Pérez-Gómez B, Navarrete-Muñoz EM, Vioque J, Pollán M, DDM-Spain. Walking, biking or sport: how Spanish women attending breast cancer screening meet physical activity recommendations?. Eur J Public Health. 2015;25 (5):857-63. doi: 10.1093/eurpub/cku248. PubMed PMID:25767095 .

  18. Castaño-Vinyals G, Aragonés N, Pérez-Gómez B, Martín V, Llorca J, Moreno V, Altzibar JM, Ardanaz E, de Sanjosé S, Jiménez-Moleón JJ, Tardón A, Alguacil J, Peiró R, Marcos-Gragera R, Navarro C, Pollán M, Kogevinas M, MCC-Spain Study Group. Population-based multicase-control study in common tumors in Spain (MCC-Spain): rationale and study design.. Gac Sanit. ;29 (4):308-15. doi: 10.1016/j.gaceta.2014.12.003. PubMed PMID:25613680 .

  19. Santos C, Sanz-Pamplona R, Nadal E, Grasselli J, Pernas S, Dienstmann R, Moreno V, Tabernero J, Salazar R. Intrinsic cancer subtypes--next steps into personalized medicine.. Cell Oncol (Dordr). 2015;38 (1):3-16. doi: 10.1007/s13402-014-0203-7. PubMed PMID:25586691 .

  20. Kopetz S, Tabernero J, Rosenberg R, Jiang ZQ, Moreno V, Bachleitner-Hofmann T, Lanza G, Stork-Sloots L, Maru D, Simon I, Capellà G, Salazar R. Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors.. Oncologist. 2015;20 (2):127-33. doi: 10.1634/theoncologist.2014-0325. PubMed PMID:25561511 PubMed Central PMC4319631.

  21. Zamora-Ros R, Shivappa N, Steck SE, Canzian F, Landi S, Alonso MH, Hébert JR, Moreno V. Dietary inflammatory index and inflammatory gene interactions in relation to colorectal cancer risk in the Bellvitge colorectal cancer case-control study.. Genes Nutr. 2015;10 (1):447. doi: 10.1007/s12263-014-0447-x. PubMed PMID:25488145 PubMed Central PMC4259879.

  22. Garcia M, Milà N, Binefa G, Benito L, Gonzalo N, Moreno V. Fecal hemoglobin concentration as a measure of risk to tailor colorectal cancer screening: are we there yet?. Eur. J. Cancer Prev. 2015;24 (4):321-7. doi: 10.1097/CEJ.0000000000000090. PubMed PMID:25370684 .

  23. Campa D, Martino A, Varkonyi J, Lesueur F, Jamroziak K, Landi S, Jurczyszyn A, Marques H, Andersen V, Jurado M, Brenner H, Petrini M, Vogel U, García-Sanz R, Buda G, Gemignani F, Ríos R, Vangsted AJ, Dumontet C, Martínez-López J, Moreno MJ, Stępień A, Wątek M, Moreno V, Dieffenbach AK, Rossi AM, Butterbach K, Jacobsen SE, Goldschmidt H, Sainz J, Hillengass J, Orciuolo E, Dudziński M, Weinhold N, Reis RM, Canzian F. Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length.. Int. J. Cancer. 2015;136 (5):E351-8. doi: 10.1002/ijc.29101. PubMed PMID:25066524 .

Search PubMed
  1. Salas LA, Gracia-Lavedan E, Goñi F, Moreno V, Villanueva CM. Use of urinary trichloroacetic acid as an exposure biomarker of disinfection by-products in cancer studies.. Environ. Res. 2014;135 :276-84. doi: 10.1016/j.envres.2014.09.018. PubMed PMID:25462676 .

  2. Fortini BK, Tring S, Plummer SJ, Edlund CK, Moreno V, Bresalier RS, Barry EL, Church TR, Figueiredo JC, Casey G. Multiple functional risk variants in a SMAD7 enhancer implicate a colorectal cancer risk haplotype.. PLoS ONE. 2014;9 (11):e111914. doi: 10.1371/journal.pone.0111914. PubMed PMID:25375357 PubMed Central PMC4223076.

  3. Cordero D, Solé X, Crous-Bou M, Sanz-Pamplona R, Paré-Brunet L, Guinó E, Olivares D, Berenguer A, Santos C, Salazar R, Biondo S, Moreno V. Large differences in global transcriptional regulatory programs of normal and tumor colon cells.. BMC Cancer. 2014;14 :708. doi: 10.1186/1471-2407-14-708. PubMed PMID:25253512 PubMed Central PMC4182786.

  4. Solé X, Crous-Bou M, Cordero D, Olivares D, Guinó E, Sanz-Pamplona R, Rodriguez-Moranta F, Sanjuan X, de Oca J, Salazar R, Moreno V. Discovery and validation of new potential biomarkers for early detection of colon cancer.. PLoS ONE. 2014;9 (9):e106748. doi: 10.1371/journal.pone.0106748. PubMed PMID:25215506 PubMed Central PMC4162553.

  5. Berdiel-Acer M, Berenguer A, Sanz-Pamplona R, Cuadras D, Sanjuan X, Paules MJ, Santos C, Salazar R, Moreno V, Capella G, Villanueva A, Molleví DG. A 5-gene classifier from the carcinoma-associated fibroblast transcriptomic profile and clinical outcome in colorectal cancer.. Oncotarget. 2014;5 (15):6437-52. doi: 10.18632/oncotarget.2237. PubMed PMID:25115384 PubMed Central PMC4171642.

  6. Wang H, Burnett T, Kono S, Haiman CA, Iwasaki M, Wilkens LR, Loo LW, Van Den Berg D, Kolonel LN, Henderson BE, Keku TO, Sandler RS, Signorello LB, Blot WJ, Newcomb PA, Pande M, Amos CI, West DW, Bézieau S, Berndt SI, Zanke BW, Hsu L, Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), Lindor NM, Haile RW, Hopper JL, Jenkins MA, Gallinger S, Casey G, Colon Cancer Family Registry (CCFR), Stenzel SL, Schumacher FR, Peters U, Gruber SB, Colorectal Transdisciplinary Study (CORECT), Tsugane S, Stram DO, Le Marchand L. Trans-ethnic genome-wide association study of colorectal cancer identifies a new susceptibility locus in VTI1A.. Nat Commun. 2014;5 :4613. doi: 10.1038/ncomms5613. PubMed PMID:25105248 PubMed Central PMC4180879.

  7. Vidal C, Garcia M, Benito L, Milà N, Binefa G, Moreno V. Use of text-message reminders to improve participation in a population-based breast cancer screening program.. J Med Syst. 2014;38 (9):118. doi: 10.1007/s10916-014-0118-x. PubMed PMID:25073694 .

  8. Bellido F, Pineda M, Sanz-Pamplona R, Navarro M, Nadal M, Lázaro C, Blanco I, Moreno V, Capellá G, Valle L. Comprehensive molecular characterisation of hereditary non-polyposis colorectal tumours with mismatch repair proficiency.. Eur. J. Cancer. 2014;50 (11):1964-72. doi: 10.1016/j.ejca.2014.04.022. PubMed PMID:24841217 .

  9. Berdiel-Acer M, Sanz-Pamplona R, Calon A, Cuadras D, Berenguer A, Sanjuan X, Paules MJ, Salazar R, Moreno V, Batlle E, Villanueva A, Molleví DG. Differences between CAFs and their paired NCF from adjacent colonic mucosa reveal functional heterogeneity of CAFs, providing prognostic information.. Mol Oncol. 2014;8 (7):1290-305. doi: 10.1016/j.molonc.2014.04.006. PubMed PMID:24839936 PubMed Central PMC5528579.

  10. Zhang B, Jia WH, Matsuda K, Kweon SS, Matsuo K, Xiang YB, Shin A, Jee SH, Kim DH, Cai Q, Long J, Shi J, Wen W, Yang G, Zhang Y, Li C, Li B, Guo Y, Ren Z, Ji BT, Pan ZZ, Takahashi A, Shin MH, Matsuda F, Gao YT, Oh JH, Kim S, Ahn YO, Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), Chan AT, Chang-Claude J, Slattery ML, Colorectal Transdisciplinary (CORECT) Study, Gruber SB, Schumacher FR, Stenzel SL, Colon Cancer Family Registry (CCFR), Casey G, Kim HR, Jeong JY, Park JW, Li HL, Hosono S, Cho SH, Kubo M, Shu XO, Zeng YX, Zheng W. Large-scale genetic study in East Asians identifies six new loci associated with colorectal cancer risk.. Nat. Genet. 2014;46 (6):533-42. doi: 10.1038/ng.2985. PubMed PMID:24836286 PubMed Central PMC4068797.

  11. Berdiel-Acer M, Cuadras D, Díaz-Maroto NG, Sanjuan X, Serrano T, Berenguer A, Moreno V, Gonçalves-Ribeiro S, Salazar R, Villanueva A, Molleví DG. A monotonic and prognostic genomic signature from fibroblasts for colorectal cancer initiation, progression, and metastasis.. Mol. Cancer Res. 2014;12 (9):1254-66. doi: 10.1158/1541-7786.MCR-14-0121. PubMed PMID:24829396 .

  12. Closa A, Cordero D, Sanz-Pamplona R, Solé X, Crous-Bou M, Paré-Brunet L, Berenguer A, Guino E, Lopez-Doriga A, Guardiola J, Biondo S, Salazar R, Moreno V. Identification of candidate susceptibility genes for colorectal cancer through eQTL analysis.. Carcinogenesis. 2014;35 (9):2039-46. doi: 10.1093/carcin/bgu092. PubMed PMID:24760461 PubMed Central PMC4146415.

  13. Marro M, Nieva C, Sanz-Pamplona R, Sierra A. Molecular monitoring of epithelial-to-mesenchymal transition in breast cancer cells by means of Raman spectroscopy.. Biochim. Biophys. Acta. 2014;1843 (9):1785-95. doi: 10.1016/j.bbamcr.2014.04.012. PubMed PMID:24747691 .

  14. Sanz-Pamplona R, Berenguer A, Cordero D, Molleví DG, Crous-Bou M, Sole X, Paré-Brunet L, Guino E, Salazar R, Santos C, de Oca J, Sanjuan X, Rodriguez-Moranta F, Moreno V. Aberrant gene expression in mucosa adjacent to tumor reveals a molecular crosstalk in colon cancer.. Mol. Cancer. 2014;13 :46. doi: 10.1186/1476-4598-13-46. PubMed PMID:24597571 PubMed Central PMC4023701.

  15. Martino A, Campa D, Jurczyszyn A, Martínez-López J, Moreno MJ, Varkonyi J, Dumontet C, García-Sanz R, Gemignani F, Jamroziak K, Stępieł A, Jacobsen SE, Andersen V, Jurado M, Landi S, Rossi AM, Lesueur F, Marques H, Dudziński M, Wątek M, Moreno V, Orciuolo E, Petrini M, Reis RM, Ríos R, Sainz J, Vogel U, Buda G, Vangsted AJ, Canzian F. Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era.. Cancer Epidemiol. Biomarkers Prev. 2014;23 (4):670-4. doi: 10.1158/1055-9965.EPI-13-1115. PubMed PMID:24521996 .

  16. Seguí N, Guinó E, Pineda M, Navarro M, Bellido F, Lázaro C, Blanco I, Moreno V, Capellá G, Valle L. Longer telomeres are associated with cancer risk in MMR-proficient hereditary non-polyposis colorectal cancer.. PLoS ONE. 2014;9 (2):e86063. doi: 10.1371/journal.pone.0086063. PubMed PMID:24498269 PubMed Central PMC3911901.

  17. Graffelman J, Sánchez M, Cook S, Moreno V. Statistical inference for Hardy-Weinberg proportions in the presence of missing genotype information.. PLoS ONE. 2013;8 (12):e83316. doi: 10.1371/journal.pone.0083316. PubMed PMID:24391752 PubMed Central PMC3877411.

  18. Lopez-Doriga A, Feliubadaló L, Menéndez M, Lopez-Doriga S, Morón-Duran FD, del Valle J, Tornero E, Montes E, Cuesta R, Campos O, Gómez C, Pineda M, González S, Moreno V, Capellá G, Lázaro C. ICO amplicon NGS data analysis: a Web tool for variant detection in common high-risk hereditary cancer genes analyzed by amplicon GS Junior next-generation sequencing.. Hum. Mutat. 2014;35 (3):271-7. doi: 10.1002/humu.22484. PubMed PMID:24227591 .

  19. Fernandez-Rozadilla C, Cazier JB, Tomlinson I, Brea-Fernández A, Lamas MJ, Baiget M, López-Fernández LA, Clofent J, Bujanda L, Gonzalez D, de Castro L, EPICOLON Consortium, Hemminki K, Bessa X, Andreu M, Jover R, Xicola R, Llor X, Moreno V, Castells A, Castellví-Bel S, Carracedo A, Ruiz-Ponte C. A genome-wide association study on copy-number variation identifies a 11q11 loss as a candidate susceptibility variant for colorectal cancer.. Hum. Genet. 2014;133 (5):525-34. doi: 10.1007/s00439-013-1390-4. PubMed PMID:24218287 .

  20. Roepman P, Schlicker A, Tabernero J, Majewski I, Tian S, Moreno V, Snel MH, Chresta CM, Rosenberg R, Nitsche U, Macarulla T, Capella G, Salazar R, Orphanides G, Wessels LF, Bernards R, Simon IM. Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition.. Int. J. Cancer. 2014;134 (3):552-62. doi: 10.1002/ijc.28387. PubMed PMID:23852808 PubMed Central PMC4234005.

Search PubMed
  1. Graffelman J, Sánchez M, Cook S, Moreno V. Statistical inference for Hardy-Weinberg proportions in the presence of missing genotype information.. PLoS ONE. 2013;8 (12):e83316. doi: 10.1371/journal.pone.0083316. PubMed PMID:24391752 PubMed Central PMC3877411.

  2. Crous-Bou M, Rennert G, Cuadras D, Salazar R, Cordero D, Saltz Rennert H, Lejbkowicz F, Kopelovich L, Monroe Lipkin S, Bernard Gruber S, Moreno V. Polymorphisms in alcohol metabolism genes ADH1B and ALDH2, alcohol consumption and colorectal cancer.. PLoS ONE. 2013;8 (11):e80158. doi: 10.1371/journal.pone.0080158. PubMed PMID:24282520 PubMed Central PMC3839967.

  3. Binefa G, García M, Milà N, Rodríguez L, Rodríguez-Moranta F, Guardiola J, Moreno V. Colonoscopy quality assessment in a mass population screening programme based on faecal occult blood test.. Rev Esp Enferm Dig. 2013;105 (7):400-8. . PubMed PMID:24206550 .

  4. Picelli S, Lorenzo Bermejo J, Chang-Claude J, Hoffmeister M, Fernández-Rozadilla C, Carracedo A, Castells A, Castellví-Bel S, Memebers of EPICOLON Consortium-Gastrointestinal Oncology Group of the Spanish Gastroenterological Association, Naccarati A, Pardini B, Vodickova L, Müller H, Talseth-Palmer BA, Stibbard G, Peterlongo P, Nici C, Veneroni S, Li L, Casey G, Tenesa A, Farrington SM, Tomlinson I, Moreno V, van Wezel T, Wijnen J, Dunlop M, Radice P, Scott RJ, Vodicka P, Ruiz-Ponte C, Brenner H, Buch S, Völzke H, Hampe J, Schafmayer C, Lindblom A. Meta-analysis of mismatch repair polymorphisms within the cogent consortium for colorectal cancer susceptibility.. PLoS ONE. 2013;8 (9):e72091. doi: 10.1371/journal.pone.0072091. PubMed PMID:24039736 PubMed Central PMC3765450.

  5. Graffelman J, Moreno V. The mid p-value in exact tests for Hardy-Weinberg equilibrium.. Stat Appl Genet Mol Biol. 2013;12 (4):433-48. doi: 10.1515/sagmb-2012-0039. PubMed PMID:23934608 .

  6. Carmona FJ, Azuara D, Berenguer-Llergo A, Fernández AF, Biondo S, de Oca J, Rodriguez-Moranta F, Salazar R, Villanueva A, Fraga MF, Guardiola J, Capellá G, Esteller M, Moreno V. DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer.. Cancer Prev Res (Phila). 2013;6 (7):656-65. doi: 10.1158/1940-6207.CAPR-12-0501. PubMed PMID:23694962 .

  7. Seguí N, Pineda M, Guinó E, Borràs E, Navarro M, Bellido F, Moreno V, Lázaro C, Blanco I, Capellá G, Valle L. Telomere length and genetic anticipation in Lynch syndrome.. PLoS ONE. 2013;8 (4):e61286. doi: 10.1371/journal.pone.0061286. PubMed PMID:23637804 PubMed Central PMC3634050.

  8. Santana-Codina N, Carretero R, Sanz-Pamplona R, Cabrera T, Guney E, Oliva B, Clezardin P, Olarte OE, Loza-Alvarez P, Méndez-Lucas A, Perales JC, Sierra A. A transcriptome-proteome integrated network identifies endoplasmic reticulum thiol oxidoreductase (ERp57) as a hub that mediates bone metastasis.. Mol. Cell Proteomics. 2013;12 (8):2111-25. doi: 10.1074/mcp.M112.022772. PubMed PMID:23625662 PubMed Central PMC3734573.

  9. Clèries R, Martínez JM, Moreno V, Yasui Y, Ribes J, Borràs JM. Predicting the change in breast cancer deaths in Spain by 2019: a Bayesian approach.. Epidemiology. 2013;24 (3):454-60. doi: 10.1097/EDE.0b013e31828b0866. PubMed PMID:23493031 .

  10. Ogbah Z, Visa L, Badenas C, Ríos J, Puig-Butille JA, Bonifaci N, Guino E, Augé JM, Kolm I, Carrera C, Pujana MÁ, Malvehy J, Puig S. Serum 25-hydroxyvitamin D3 levels and vitamin D receptor variants in melanoma patients from the Mediterranean area of Barcelona.. BMC Med. Genet. 2013;14 :26. doi: 10.1186/1471-2350-14-26. PubMed PMID:23413917 PubMed Central PMC3648347.

  11. Fernandez-Rozadilla C, Cazier JB, Tomlinson IP, Carvajal-Carmona LG, Palles C, Lamas MJ, Baiget M, López-Fernández LA, Brea-Fernández A, Abulí A, Bujanda L, Clofent J, Gonzalez D, Xicola R, Andreu M, Bessa X, Jover R, Llor X, EPICOLON Consortium, Moreno V, Castells A, Carracedo Á, Castellvi-Bel S, Ruiz-Ponte C. A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12.. BMC Genomics. 2013;14 :55. doi: 10.1186/1471-2164-14-55. PubMed PMID:23350875 PubMed Central PMC3616862.

  12. Martino A, Sainz J, Manuel Reis R, Moreno V, Buda G, Lesueur F, Marques H, García-Sanz R, Ríos R, Stein A, Dumontet C, Gemignani F, Maria Rossi A, Landi S, Jurado M, Petrini M, Jamroziak K, Campa D, Canzian F. Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: a case-control study in the context of the IMMEnSE consortium.. J. Hum. Genet. 2013;58 (3):155-9. doi: 10.1038/jhg.2012.149. PubMed PMID:23303387 .

  13. Santos C, López-Doriga A, Navarro M, Mateo J, Biondo S, Martínez Villacampa M, Soler G, Sanjuan X, Paules MJ, Laquente B, Guinó E, Kreisler E, Frago R, Germà JR, Moreno V, Salazar R. Clinicopathological risk factors of Stage II colon cancer: results of a prospective study.. Colorectal Dis. 2013;15 (4):414-22. doi: 10.1111/codi.12028. PubMed PMID:22974322 .

  14. Tian S, Simon I, Moreno V, Roepman P, Tabernero J, Snel M, van't Veer L, Salazar R, Bernards R, Capella G. A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction.. Gut. 2013;62 (4):540-9. doi: 10.1136/gutjnl-2012-302423. PubMed PMID:22798500 PubMed Central PMC3596735.

  15. Zamora-Ros R, Not C, Guinó E, Luján-Barroso L, García RM, Biondo S, Salazar R, Moreno V. Association between habitual dietary flavonoid and lignan intake and colorectal cancer in a Spanish case-control study (the Bellvitge Colorectal Cancer Study).. Cancer Causes Control. 2013;24 (3):549-57. doi: 10.1007/s10552-012-9992-z. PubMed PMID:22588680 .

  16. Azuara D, Rodriguez-Moranta F, de Oca J, Sanjuan X, Guardiola J, Lobaton T, Wang A, Boadas J, Piqueras M, Monfort D, Galter S, Esteller M, Moreno V, Capellá G. Novel methylation panel for the early detection of neoplasia in high-risk ulcerative colitis and Crohn's colitis patients.. Inflamm. Bowel Dis. 2013;19 (1):165-73. doi: 10.1002/ibd.22994. PubMed PMID:22532293 .

Search PubMed
  1. Feliubadaló L, Lopez-Doriga A, Castellsagué E, del Valle J, Menéndez M, Tornero E, Montes E, Cuesta R, Gómez C, Campos O, Pineda M, González S, Moreno V, Brunet J, Blanco I, Serra E, Capellá G, Lázaro C. Next-generation sequencing meets genetic diagnostics: development of a comprehensive workflow for the analysis of BRCA1 and BRCA2 genes.. Eur. J. Hum. Genet. 2013;21 (8):864-70. doi: 10.1038/ejhg.2012.270. PubMed PMID:23249957 PubMed Central PMC3722680.

  2. Fernandez-Rozadilla C, Palles C, Carvajal-Carmona L, Peterlongo P, Nici C, Veneroni S, Pinheiro M, Teixeira MR, Moreno V, Lamas MJ, Baiget M, Lopez-Fernandez LA, Gonzalez D, Brea-Fernandez A, Clofent J, Bujanda L, Bessa X, Andreu M, Xicola R, Llor X, Jover R, EPICOLON Consortium, Castells A, Castellvi-Bel S, Carracedo A, Tomlinson I, Ruiz-Ponte C. BMP2/BMP4 colorectal cancer susceptibility loci in northern and southern European populations.. Carcinogenesis. 2013;34 (2):314-8. doi: 10.1093/carcin/bgs357. PubMed PMID:23161572 .

  3. Sanz-Pamplona R, Berenguer A, Cordero D, Riccadonna S, Solé X, Crous-Bou M, Guinó E, Sanjuan X, Biondo S, Soriano A, Jurman G, Capella G, Furlanello C, Moreno V. Clinical value of prognosis gene expression signatures in colorectal cancer: a systematic review.. PLoS ONE. 2012;7 (11):e48877. doi: 10.1371/journal.pone.0048877. PubMed PMID:23145004 PubMed Central PMC3492249.

  4. Moreira L, Balaguer F, Lindor N, de la Chapelle A, Hampel H, Aaltonen LA, Hopper JL, Le Marchand L, Gallinger S, Newcomb PA, Haile R, Thibodeau SN, Gunawardena S, Jenkins MA, Buchanan DD, Potter JD, Baron JA, Ahnen DJ, Moreno V, Andreu M, Ponz de Leon M, Rustgi AK, Castells A, EPICOLON Consortium. Identification of Lynch syndrome among patients with colorectal cancer.. JAMA. 2012;308 (15):1555-65. doi: 10.1001/jama.2012.13088. PubMed PMID:23073952 PubMed Central PMC3873721.

  5. Bellido F, Guinó E, Jagmohan-Changur S, Seguí N, Pineda M, Navarro M, Lázaro C, Blanco I, Vasen HF, Moreno V, Capellá G, Wijnen JT, Valle L. Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome.. Eur. J. Hum. Genet. 2013;21 (5):511-6. doi: 10.1038/ejhg.2012.204. PubMed PMID:22948024 PubMed Central PMC3641380.

  6. Martino A, Campa D, Jamroziak K, Reis RM, Sainz J, Buda G, García-Sanz R, Lesueur F, Marques H, Moreno V, Jurado M, Ríos R, Szemraj-Rogucka Z, Szemraj J, Tjønneland A, Overvad K, Vangsted AJ, Vogel U, Mikala G, Kádár K, Szombath G, Varkonyi J, Orciuolo E, Dumontet C, Gemignani F, Rossi AM, Landi S, Petrini M, Houlston RS, Hemminki K, Canzian F. Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma.. Br. J. Haematol. 2012;158 (6):805-9. doi: 10.1111/j.1365-2141.2012.09244.x. PubMed PMID:22823248 .

  7. Azuara D, Ginesta MM, Gausachs M, Rodriguez-Moranta F, Fabregat J, Busquets J, Pelaez N, Boadas J, Galter S, Moreno V, Costa J, de Oca J, Capellá G. Nanofluidic digital PCR for KRAS mutation detection and quantification in gastrointestinal cancer.. Clin. Chem. 2012;58 (9):1332-41. doi: 10.1373/clinchem.2012.186577. PubMed PMID:22745110 .

  8. Sanz-Pamplona R, García-García J, Franco S, Messeguer X, Driouch K, Oliva B, Sierra A. A taxonomy of organ-specific breast cancer metastases based on a protein-protein interaction network.. Mol Biosyst. 2012;8 (8):2085-96. doi: 10.1039/c2mb25104c. PubMed PMID:22710377 .

  9. Garcia M, Milà N, Binefa G, Borràs JM, Espinàs JA, Moreno V. False-positive results from colorectal cancer screening in Catalonia (Spain), 2000-2010.. J Med Screen. 2012;19 (2):77-82. doi: 10.1258/jms.2012.012013. PubMed PMID:22653571 .

  10. Campa D, Martino A, Sainz J, Buda G, Jamroziak K, Weinhold N, Vieira Reis RM, García-Sanz R, Jurado M, Ríos R, Szemraj-Rogucka Z, Marques H, Lesueur F, Bugert P, Moreno V, Szemraj J, Orciuolo E, Gemignani F, Rossi AM, Dumontet C, Petrini M, Goldschmidt H, Landi S, Canzian F. Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium.. Br. J. Haematol. 2012;157 (3):331-8. . PubMed PMID:22590720 .

  11. Perea MD, Castaño-Vinyals G, Altzibar JM, Ascunce N, Moreno V, Tardon A, Pollán M, Sala M, MCC-Spain. [Cancer screening practices and associated lifestyles in population controls of the Spanish multi-case control study].. Gac Sanit. ;26 (4):301-10. doi: 10.1016/j.gaceta.2012.01.020. PubMed PMID:22522032 .

  12. Barderas R, Babel I, Díaz-Uriarte R, Moreno V, Suárez A, Bonilla F, Villar-Vázquez R, Capellá G, Casal JI. An optimized predictor panel for colorectal cancer diagnosis based on the combination of tumor-associated antigens obtained from protein and phage microarrays.. J Proteomics. 2012;75 (15):4647-55. doi: 10.1016/j.jprot.2012.03.004. PubMed PMID:22465712 .

  13. Villanueva CM, Castaño-Vinyals G, Moreno V, Carrasco-Turigas G, Aragonés N, Boldo E, Ardanaz E, Toledo E, Altzibar JM, Zaldua I, Azpiroz L, Goñi F, Tardón A, Molina AJ, Martín V, López-Rojo C, Jiménez-Moleón JJ, Capelo R, Gómez-Acebo I, Peiró R, Ripoll M, Gracia-Lavedan E, Nieuwenhujsen MJ, Rantakokko P, Goslan EH, Pollán M, Kogevinas M. Concentrations and correlations of disinfection by-products in municipal drinking water from an exposure assessment perspective.. Environ. Res. 2012;114 :1-11. doi: 10.1016/j.envres.2012.02.002. PubMed PMID:22436294 .

  14. Stresing V, Baltziskueta E, Rubio N, Blanco J, Arriba MC, Valls J, Janier M, Clézardin P, Sanz-Pamplona R, Nieva C, Marro M, Petrov D, Dmitri P, Sierra A. Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs.. Oncogene. 2013;32 (6):724-35. doi: 10.1038/onc.2012.93. PubMed PMID:22430214 .

  15. Della Gatta G, Palomero T, Perez-Garcia A, Ambesi-Impiombato A, Bansal M, Carpenter ZW, De Keersmaecker K, Sole X, Xu L, Paietta E, Racevskis J, Wiernik PH, Rowe JM, Meijerink JP, Califano A, Ferrando AA. Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL.. Nat. Med. 2012;18 (3):436-40. doi: 10.1038/nm.2610. PubMed PMID:22366949 PubMed Central PMC3298036.

  16. Milà N, García M, Binefa G, Borràs JM, Espinàs JA, Moreno V. [Adherence to a population-based colorectal cancer screening program in Catalonia (Spain), 2000-2008].. Gac Sanit. ;26 (3):217-22. doi: 10.1016/j.gaceta.2011.10.020. PubMed PMID:22361637 .

  17. Fernandez-Rozadilla C, Cazier JB, Moreno V, Crous-Bou M, Guinó E, Durán G, Lamas MJ, López R, Candamio S, Gallardo E, Paré L, Baiget M, Páez D, López-Fernández LA, Cortejoso L, García MI, Bujanda L, González D, Gonzalo V, Rodrigo L, Reñé JM, Jover R, Brea-Fernández A, Andreu M, Bessa X, Llor X, Xicola R, Palles C, Tomlinson I, Castellví-Bel S, Castells A, Ruiz-Ponte C, Carracedo A, EPICOLON Consortium. Pharmacogenomics in colorectal cancer: a genome-wide association study to predict toxicity after 5-fluorouracil or FOLFOX administration.. Pharmacogenomics J. 2013;13 (3):209-17. doi: 10.1038/tpj.2012.2. PubMed PMID:22310351 .

  18. Crous-Bou M, Rennert G, Salazar R, Rodriguez-Moranta F, Rennert HS, Lejbkowicz F, Kopelovich L, Lipkin SM, Gruber SB, Moreno V. Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer.. Mutagenesis. 2012;27 (2):169-76. doi: 10.1093/mutage/ger066. PubMed PMID:22294764 PubMed Central PMC3269001.

  19. Houlston RS, members of COGENT. COGENT (COlorectal cancer GENeTics) revisited.. Mutagenesis. 2012;27 (2):143-51. doi: 10.1093/mutage/ger059. PubMed PMID:22294761 PubMed Central PMC3269000.

  20. Sanz-Pamplona R, Berenguer A, Sole X, Cordero D, Crous-Bou M, Serra-Musach J, Guinó E, Pujana MÁ, Moreno V. Tools for protein-protein interaction network analysis in cancer research.. Clin Transl Oncol. 2012;14 (1):3-14. . PubMed PMID:22262713 .

  21. Giráldez MD, López-Dóriga A, Bujanda L, Abulí A, Bessa X, Fernández-Rozadilla C, Muñoz J, Cuatrecasas M, Jover R, Xicola RM, Llor X, Piqué JM, Carracedo A, Ruiz-Ponte C, Cosme A, Enríquez-Navascués JM, Moreno V, Andreu M, Castells A, Balaguer F, Castellví-Bel S, Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Susceptibility genetic variants associated with early-onset colorectal cancer.. Carcinogenesis. 2012;33 (3):613-9. doi: 10.1093/carcin/bgs009. PubMed PMID:22235025 .

  22. Martino A, Sainz J, Buda G, Jamroziak K, Reis RM, García-Sanz R, Jurado M, Ríos R, Szemraj-Rogucka Z, Marques H, Lesueur F, Moreno V, Orciuolo E, Gemignani F, Landi S, Rossi AM, Dumontet C, Petrini M, Campa D, Canzian F. Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review).. Int. J. Oncol. 2012;40 (3):625-38. doi: 10.3892/ijo.2011.1284. PubMed PMID:22159523 .

  23. Garcia M, Borràs JM, Binefa G, Milà N, Espinàs JA, Moreno V. Repeated screening for colorectal cancer with fecal occult blood test in Catalonia, Spain.. Eur. J. Cancer Prev. 2012;21 (1):42-5. doi: 10.1097/CEJ.0b013e32834a7e9b. PubMed PMID:21849903 .

  24. Saunders IW, Ross J, Macrae F, Young GP, Blanco I, Brohede J, Brown G, Brookes D, Lockett T, Molloy PL, Moreno V, Capella G, Hannan GN. Evidence of linkage to chromosomes 10p15.3-p15.1, 14q24.3-q31.1 and 9q33.3-q34.3 in non-syndromic colorectal cancer families.. Eur. J. Hum. Genet. 2012;20 (1):91-6. doi: 10.1038/ejhg.2011.149. PubMed PMID:21829229 PubMed Central PMC3234517.

  25. Peters U, Hutter CM, Hsu L, Schumacher FR, Conti DV, Carlson CS, Edlund CK, Haile RW, Gallinger S, Zanke BW, Lemire M, Rangrej J, Vijayaraghavan R, Chan AT, Hazra A, Hunter DJ, Ma J, Fuchs CS, Giovannucci EL, Kraft P, Liu Y, Chen L, Jiao S, Makar KW, Taverna D, Gruber SB, Rennert G, Moreno V, Ulrich CM, Woods MO, Green RC, Parfrey PS, Prentice RL, Kooperberg C, Jackson RD, Lacroix AZ, Caan BJ, Hayes RB, Berndt SI, Chanock SJ, Schoen RE, Chang-Claude J, Hoffmeister M, Brenner H, Frank B, Bézieau S, Küry S, Slattery ML, Hopper JL, Jenkins MA, Le Marchand L, Lindor NM, Newcomb PA, Seminara D, Hudson TJ, Duggan DJ, Potter JD, Casey G. Meta-analysis of new genome-wide association studies of colorectal cancer risk.. Hum. Genet. 2012;131 (2):217-34. doi: 10.1007/s00439-011-1055-0. PubMed PMID:21761138 PubMed Central PMC3257356.

  26. Sala N, Muñoz X, Travier N, Agudo A, Duell EJ, Moreno V, Overvad K, Tjonneland A, Boutron-Ruault MC, Clavel-Chapelon F, Canzian F, Kaaks R, Boeing H, Meidtner K, Trichopoulos A, Tsiotas K, Zylis D, Vineis P, Panico S, Palli D, Krogh V, Tumino R, Lund E, Bueno-de-Mesquita HB, Numans ME, Peeters PH, Quirós JR, Sánchez MJ, Navarro C, Ardanaz E, Dorronsoro M, Hallmans G, Stenling R, Manjer J, Allen NE, Travis RC, Khaw KT, Jenab M, Offerhaus GJ, Riboli E, González CA. Prostate stem-cell antigen gene is associated with diffuse and intestinal gastric cancer in Caucasians: results from the EPIC-EURGAST study.. Int. J. Cancer. 2012;130 (10):2417-27. doi: 10.1002/ijc.26243. PubMed PMID:21681742 .

  27. Fernandez AF, Assenov Y, Martin-Subero JI, Balint B, Siebert R, Taniguchi H, Yamamoto H, Hidalgo M, Tan AC, Galm O, Ferrer I, Sanchez-Cespedes M, Villanueva A, Carmona J, Sanchez-Mut JV, Berdasco M, Moreno V, Capella G, Monk D, Ballestar E, Ropero S, Martinez R, Sanchez-Carbayo M, Prosper F, Agirre X, Fraga MF, Graña O, Perez-Jurado L, Mora J, Puig S, Prat J, Badimon L, Puca AA, Meltzer SJ, Lengauer T, Bridgewater J, Bock C, Esteller M. A DNA methylation fingerprint of 1628 human samples.. Genome Res. 2012;22 (2):407-19. doi: 10.1101/gr.119867.110. PubMed PMID:21613409 PubMed Central PMC3266047.

Search PubMed
  1. García Martínez M, Binefa Rodríguez G, Milà Díaz N, Rodríguez Moranta F, Gonzalo Diego N, Muñoz Sánchez C, Espinàs Piñol JA, Borràs Andrés JM, Moreno Aguado V. [Evaluating colorectal cancer screening strategies (immunological test vs biochemical test) in Catalonia, Spain 2008-2010].. Rev. Esp. Salud Publica. 2011;85 (6):593-602. doi: 10.1590/S1135-57272011120000008. PubMed PMID:22249590 .

  2. Maxwell CA, Benítez J, Gómez-Baldó L, Osorio A, Bonifaci N, Fernández-Ramires R, Costes SV, Guinó E, Chen H, Evans GJ, Mohan P, Català I, Petit A, Aguilar H, Villanueva A, Aytes A, Serra-Musach J, Rennert G, Lejbkowicz F, Peterlongo P, Manoukian S, Peissel B, Ripamonti CB, Bonanni B, Viel A, Allavena A, Bernard L, Radice P, Friedman E, Kaufman B, Laitman Y, Dubrovsky M, Milgrom R, Jakubowska A, Cybulski C, Gorski B, Jaworska K, Durda K, Sukiennicki G, Lubiński J, Shugart YY, Domchek SM, Letrero R, Weber BL, Hogervorst FB, Rookus MA, Collee JM, Devilee P, Ligtenberg MJ, Luijt RB, Aalfs CM, Waisfisz Q, Wijnen J, Roozendaal CE, HEBON, EMBRACE, Easton DF, Peock S, Cook M, Oliver C, Frost D, Harrington P, Evans DG, Lalloo F, Eeles R, Izatt L, Chu C, Eccles D, Douglas F, Brewer C, Nevanlinna H, Heikkinen T, Couch FJ, Lindor NM, Wang X, Godwin AK, Caligo MA, Lombardi G, Loman N, Karlsson P et al.. Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer.. PLoS Biol. 2011;9 (11):e1001199. doi: 10.1371/journal.pbio.1001199. PubMed PMID:22110403 PubMed Central PMC3217025.

  3. Sanz-Pamplona R, Cordero D, Berenguer A, Lejbkowicz F, Rennert H, Salazar R, Biondo S, Sanjuan X, Pujana MA, Rozek L, Giordano TJ, Ben-Izhak O, Cohen HI, Trougouboff P, Bejhar J, Sova Y, Rennert G, Gruber SB, Moreno V. Gene expression differences between colon and rectum tumors.. Clin. Cancer Res. 2011;17 (23):7303-12. doi: 10.1158/1078-0432.CCR-11-1570. PubMed PMID:21976543 PubMed Central PMC3229689.

  4. Abulí A, Fernández-Rozadilla C, Alonso-Espinaco V, Muñoz J, Gonzalo V, Bessa X, González D, Clofent J, Cubiella J, Morillas JD, Rigau J, Latorre M, Fernández-Bañares F, Peña E, Riestra S, Payá A, Jover R, Xicola RM, Llor X, Carvajal-Carmona L, Villanueva CM, Moreno V, Piqué JM, Carracedo A, Castells A, Andreu M, Ruiz-Ponte C, Castellví-Bel S, Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Case-control study for colorectal cancer genetic susceptibility in EPICOLON: previously identified variants and mucins.. BMC Cancer. 2011;11 :339. doi: 10.1186/1471-2407-11-339. PubMed PMID:21819567 PubMed Central PMC3176240.

  5. Sanz-Pamplona R, Aragüés R, Driouch K, Martín B, Oliva B, Gil M, Boluda S, Fernández PL, Martínez A, Moreno V, Acebes JJ, Lidereau R, Reyal F, Van de Vijver MJ, Sierra A. Expression of endoplasmic reticulum stress proteins is a candidate marker of brain metastasis in both ErbB-2+ and ErbB-2- primary breast tumors.. Am. J. Pathol. 2011;179 (2):564-79. doi: 10.1016/j.ajpath.2011.04.037. PubMed PMID:21708117 PubMed Central PMC3157240.

  6. Castaño-Vinyals G, Nieuwenhuijsen MJ, Moreno V, Carrasco E, Guinó E, Kogevinas M, Villanueva CM. Participation rates in the selection of population controls in a case-control study of colorectal cancer using two recruitment methods.. Gac Sanit. ;25 (5):353-6. doi: 10.1016/j.gaceta.2010.05.011. PubMed PMID:21703726 .

  7. Marcuello E, Páez D, Paré L, Salazar J, Sebio A, del Rio E, Baiget M. A genotype-directed phase I-IV dose-finding study of irinotecan in combination with fluorouracil/leucovorin as first-line treatment in advanced colorectal cancer.. Br. J. Cancer. 2011;105 (1):53-7. doi: 10.1038/bjc.2011.206. PubMed PMID:21654688 PubMed Central PMC3137420.

  8. Boonstra PS, Mukherjee B, Taylor JM, Nilbert M, Moreno V, Gruber SB. Bayesian modeling for genetic anticipation in presence of mutational heterogeneity: a case study in Lynch syndrome.. Biometrics. 2011;67 (4):1627-37. doi: 10.1111/j.1541-0420.2011.01607.x. PubMed PMID:21627626 PubMed Central PMC3176998.

  9. Sandoval J, Heyn H, Moran S, Serra-Musach J, Pujana MA, Bibikova M, Esteller M. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome.. Epigenetics. 2011;6 (6):692-702. . PubMed PMID:21593595 .

  10. Bonifaci N, Palafox M, Pellegrini P, Osorio A, Benítez J, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Roversi G, Barile M, Viel A, Mariette F, Bernard L, Radice P, Kaufman B, Laitman Y, Milgrom R, Friedman E, Sáez ME, Climent F, Soler MT, Diez O, Balmaña J, Lasa A, Ramón y Cajal T, Miramar MD, de la Hoya M, Pérez-Segura P, Caldés T, Moreno V, Urruticoechea A, Brunet J, Lázaro C, Blanco I, Pujana MA, González-Suárez E. Evidence for a link between TNFRSF11A and risk of breast cancer.. Breast Cancer Res. Treat. 2011;129 (3):947-54. doi: 10.1007/s10549-011-1546-7. PubMed PMID:21541702 .

  11. Martrat G, Maxwell CM, Tominaga E, Porta-de-la-Riva M, Bonifaci N, Gómez-Baldó L, Bogliolo M, Lázaro C, Blanco I, Brunet J, Aguilar H, Fernández-Rodríguez J, Seal S, Renwick A, Rahman N, Kühl J, Neveling K, Schindler D, Ramírez MJ, Castellà M, Hernández G, EMBRACE, Easton DF, Peock S, Cook M, Oliver CT, Frost D, Platte R, Evans DG, Lalloo F, Eeles R, Izatt L, Chu C, Davidson R, Ong KR, Cook J, Douglas F, Hodgson S, Brewer C, Morrison PJ, Porteous M, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Roversi G, Barile M, Viel A, Pasini B, Ottini L, Putignano AL, Savarese A, Bernard L, Radice P, Healey S, Spurdle A, Chen X, Beesley J, kConFab, Rookus MA, Verhoef S, Tilanus-Linthorst MA, Vreeswijk MP, Asperen CJ, Bodmer D, Ausems MG, van Os TA, Blok MJ, Meijers-Heijboer HE, Hogervorst FB, HEBON, Goldgar DE, Buys S, John EM, Miron A, Southey M, Daly MB, BCFR, SWE-BRCA, Harbst K et al.. Exploring the link between MORF4L1 and risk of breast cancer.. Breast Cancer Res. 2011;13 (2):R40. doi: 10.1186/bcr2862. PubMed PMID:21466675 PubMed Central PMC3219203.

  12. Mukherjee B, Rennert G, Ahn J, Dishon S, Lejbkowicz F, Rennert HS, Shiovitz S, Moreno V, Gruber SB. High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation.. Gastroenterology. 2011;140 (7):1919-26. doi: 10.1053/j.gastro.2011.02.071. PubMed PMID:21419771 PubMed Central PMC4835182.

  13. García M, Borràs JM, Milà N, Espinàs JA, Binefa G, Fernández E, Farré A, Pla M, Cardona A, Moreno V. Factors associated with initial participation in a population-based screening for colorectal cancer in Catalonia, Spain: a mixed-methods study.. Prev Med. ;52 (3-4):265-7. doi: 10.1016/j.ypmed.2011.01.012. PubMed PMID:21295061 .

  14. Park K. Enhanced delivery to endothelial lysosomes by ICAM-1-targeted nanocarriers.. J Control Release. 2011;149 (3):207-8. doi: 10.1016/j.jconrel.2011.01.012. PubMed PMID:21238515 .

  15. Babel I, Barderas R, Diaz-Uriarte R, Moreno V, Suarez A, Fernandez-Aceñero MJ, Salazar R, Capellá G, Casal JI. Identification of MST1/STK4 and SULF1 proteins as autoantibody targets for the diagnosis of colorectal cancer by using phage microarrays.. Mol. Cell Proteomics. 2011;10 (3):M110.001784. doi: 10.1074/mcp.M110.001784. PubMed PMID:21228115 PubMed Central PMC3047148.

  16. Seguí N, Stevens KN, Guinó E, Rozek LS, Moreno VR, Capellá G, Gruber SB, Valle L. No association between germline allele-specific expression of TGFBR1 and colorectal cancer risk in Caucasian and Ashkenazi populations.. Br. J. Cancer. 2011;104 (4):735-40. doi: 10.1038/sj.bjc.6606079. PubMed PMID:21224855 PubMed Central PMC3049588.

  17. Salazar R, Roepman P, Capella G, Moreno V, Simon I, Dreezen C, Lopez-Doriga A, Santos C, Marijnen C, Westerga J, Bruin S, Kerr D, Kuppen P, van de Velde C, Morreau H, Van Velthuysen L, Glas AM, Van't Veer LJ, Tollenaar R. Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer.. J. Clin. Oncol. 2011;29 (1):17-24. doi: 10.1200/JCO.2010.30.1077. PubMed PMID:21098318 .

  18. Landi D, Moreno V, Guino E, Vodicka P, Pardini B, Naccarati A, Canzian F, Barale R, Gemignani F, Landi S. Polymorphisms affecting micro-RNA regulation and associated with the risk of dietary-related cancers: a review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer.. Mutat. Res. 2011;717 (1-2):109-15. doi: 10.1016/j.mrfmmm.2010.10.002. PubMed PMID:20971123 .

  19. Nakahara I. [Experimental studies on the changes of mitochondrial membrane phospholipids during cerebral ischemia and recirculation].. Nihon Geka Hokan. 1990;59 (1):27-38. . PubMed PMID:2130766 .

Search PubMed